CBD Live 1

Say He o to ha y skin

Behind the

Scenes

The Editor Róisín Delaney

Assistant Editor Gordon Stribling

Journalist Caroline Barry

Creative Director James Parnell

Head of Design Hayley Parker

Lead Graphic Designer Connor Dimberline

Junior Graphic Designer Ayaz Arshad

Junior Graphic Designer Lewis Eyre

Junior Graphic Designer Aaron Rana

Design Support Lucy Booth

Marketing Manager Katie Loomes

Senior Web Developer Aadil Popat

Junior Web Developer Kain Alden

Marketing Executive Carrie Strouther

Photographer Robyn Keetley

Finance Director Joanne Stubley

Accountant Kris Worton

Finance Executive Anna Difusco

Finance Executive Rochelle Warsop

General Manager Abida Razaque

Sales Manager Steve Culf Sales Supervisor Tom Slack Sales Executive Jason Bacon Sales Executive Baz Bassra Sales Executive Peter Masters

Sales Executive Carl Mayes

Director Pom Kaila

Director David Turner

Managing Director Paul Caplin

This publication and the products shown herein are intended for an adult audience. The comments and opinions given by contributors to this publication are not the views of the editor or magazine, unless otherwise stated. The products featured in this magazine are not sponsored and have been included at the decision of the editor / publisher and were not seen or altered by the suppliers in any way prior to publication. While every effort is made to respect editorial and advertising standards, The CANNAVIST cannot accept liability for issues raised or comments made by those featured in this magazine. Should you have a query about the content in this publication, email the editor: roisin@cannavistmag.com

Editor’s Letter

Welcome to the land of CBD LIVE at VOXPO! Where anything is possible.

It doesn’t matter what you wear or what time you show up at. You don’t need an expo pass, you don’t even need to pay to register. Forget travel and accommodation fees or lugging the contents of an exhibition stand in tow. We created the CBD LIVE at VOXPO concept to conveniently reunite the legal cannabis community after what has been a tumultuous five months.

No fuss, no mess, no unnecessary costs. Instead we have created a growing space of unlimited opportunities. Whether you are in a suit, yoga leggings or pyjamas, you are most welcome to what promises to be an action packed three-day online event.

Anything goes when you host an event like this. Log in from the office, your WFH space or even your bed (especially if you’re joining us on Sunday morning!) We’re just glad to have you on board with what is our first largescale event at The CANNAVIST.

This weekend marks the first of four virtual expos we have planned for the coming year. That’s right, not just one trade show, we’re talking three-day live events, four times a year between now and July 2021. We’ll be adjusting time zones and targeting regions as we go, but more on that later in this brochure.

The idea for this came about when suddenly, every event we were signed up to as a media partner just ceased

travel to or exhibit at, and this was to the detriment of the industry as a whole. So many great events, largely education based, have suffered due to COVID-19 and sadly some may never return.

What does this mean for consumers, those most curious about CBD and medical cannabis? It narrows their learning opportunities and results in a reliance forming on Dr Internet, which we all know isn’t the best place to start. Some events will return defiantly next year and we will be more than ready when that happens! In the meantime, we invite you to join us as we traverse the virtual world and gather as one global cannabis community to teach, eradicate stigma and most importantly learn from one another. Namaste!

Róisín Delaney | The Editor

The CANNAVIST is published by Orange Fox Media Limited in Derby, United Kingdom. This publication is printed and distributed by Warners Group Publications in the UK.

The CANNAVIST is a member of the Independent Press Standards Organisation and as such abides by the Editors’ Code of Practice in committing to upholding the highest standards of journalism.

If you think such a standard has not been met in this issue of the magazine, and you would like to make a complaint, email the editor at editorial@cannavistmag.com. We will endeavour to respond to your complaint as soon as possible, or within five working days. If we are unable to resolve your complaint, or if you would like more information about the IPSO Editors’ Code, go to ipso.co.uk. The CANNAVIST (print) ISSN: 2633-4097. The Cannavist is a registered trademark.

For all advertising enquiries email: advertising@cannavistmag.com. For event enquiries, email: events@cannavistmag.com. Got an editorial opportunity or work in PR? Email the editorial team: editorial@cannavistmag.com. For more information about this magazine, go to Cannavistmag.com or call the head office on 0044 (0) 1332 650 239. Office hours are Monday-Friday, 9am-5pm.

CONTENTS

INTRODUCTION / OVERVIEW 14 WHO IS EXHIBITING? 22 WHO IS SPEAKING? ........................................................................... 34

SCHEDULE OF SPEAKERS 42

NEWS IN BRIEF: THE EXTRACT 58

LIFE AFTER COVID-19 74

CBD POTENTIAL IN THE PET ECONOMY 76

THE YEAR IN CBD STUDIES 90

CBD LIVE AT VOXPO PRESENTS THREE DAYS OF EDUCATION, PASSION AND OPPORTUNITIES.

Here’s a taste of what to expect.

EDUCATION

Learning around CBD and medical cannabis depends on science and communication. At The CANNAVIST, it’s our goal to put education first, to work towards normalising CBD and the medical components of cannabis, which are very much a taboo still in 2020.

At CBD LIVE, we endeavour to bring you the science of cannabis in a way in which you can easily understand. For this, our first virtual event, we have gathered over 30 of the most knowledgeable minds on CBD and cannabinoid research, policy and medicine. Our globally renowned experts will guide you over the weekend to further your learning. Whether you are interested in CBD for personal use, or how the medical cannabis system

works. Maybe you’d like to know what the chances of cannabis legalisation are in the UK or how to successfully market a CBD product. Whatever your question, the CBD LIVE Auditorium is your first port of call for answers.

Our schedule is packed with three days of content from our range of key speakers. That’s three whole days of information for you to absorb and take away.

Don’t worry if you can’t make it online to every single talk or presentation, the auditorium isn’t going anywhere. You can log in the following day, the next week or month and all of the content will still be there. Notepads at the ready!

PASSION

The CBD and medical cannabis community in the UK is one of the most passionate groups we have ever come across. From support to lobbying to fundraising for medical cannabis prescriptions, we believe the legal cannabis community represents the best of humanity. It’s grown to change minds and governments and has guided conventional medical professionals in showing them why there is a need for a change of perspective on plant medicine. It has created a movement which has changed the laws in both the UK and Ireland. That’s why we’ve asked experts from the following organisations to come on board and use VOXPO as a platform to spread the facts on legal cannabis, and ultimately help prevent the spread of further stigma. We are delighted to have the Centre for Medicinal Cannabis and the Association for the Cannabinoid Industry as our official UK education partners to CBD LIVE. We’re equally proud to have US trade body, the CBD & Cannabinoid Industry Association as our US education partner. We have also linked up with expert market analysts at CBD-Intel, whose passion for the industry rings true in each and every presentation. Women Empowered in Cannabis is another unstoppable force in this community and is making opportunities for women to succeed in the cannabis space as we speak. London Canna Group, the creators of the Europe Canna Expo, which sadly had to divert its course to 2021, are also on board for CBD LIVE as a media partner and will also contribute to the auditorium.

OPPORTUNITIES

The VOXPO platform was created to support two niche industries in their time of need. That’s no exaggeration of the facts. For both the CBD and vape industries, the pandemic presented a scenario of sink or swim and unfortunately, many firms in both sectors will not return to operations. As your hosts, it is our mission to help this industry rediscover its mojo, to revitalise networking as if we were face-to-face at a physical expo, and to create a space where profitable opportunities can be made.

According to the Office for National Statistics, four out of five British businesses which have continued to trade

despite the pandemic have furloughed a percentage of their workforce. Unemployment rates across the UK are predicted to surge as the furlough scheme is wound up, and experts warn this could contribute to as many as 3.5 million Brits being unemployed by the end of the year. At the same time, CBD use and interest has skyrocketed in recent months as the public look for natural methods of easing anxiety. Eight million adults in the UK (equivalent to 15% of the population) purchased CBD products in the first half of the year, exceeding £150 million in retail value. All previous trajectories for this period have been smashed, with the British market now set to be valued at £450 million, an increase of 50% growth compared to £300 million in 2019.

Why does this matter to us? We believe platforms like VOXPO can give rise to new business opportunities, create new revenue ideas, and help curate a new age register of consumer interest in CBD. Combined, these three factors may result in companies making the ultimate comeback from corona times. As brands take in more revenue, they can begin to redevelop their workforce by investing in people in what is already a burgeoning industry. We invite all business owners and representatives to get talking, make the first move, treat this weekend as a fresh start. Don’t forget to check out our business lounge which is LinkedIn integrated.

FLY AWAY WITH VOXPO AIRWAYS

WELCOME TO CBD LIVE

Thank you for logging on to the only virtual destination for CBD this summer.

Travel and public health restrictions have led to pretty much every CBD and medical cannabis event being cancelled since March. And while that was of course necessary in the fight against COVID-19, it’s left all of these gaps in learning, and in networking. The conversations we were having at CBD parties, workshops and wellness events haven’t been happening. Meanwhile, we’ve all been bound to the confines of our borders.

At The CANNAVIST we have joined forces with our sister publication Vapouround to present this new virtual learning platform, VOXPO.

VOXPO is an exhibition house which will be available online 24/7, 365 days a year.

CBD LIVE at VOXPO offers an expo complete with the educational resources you’ve been lacking over the lockdown period.

If you are interested in dipping your toe into the ocean of legal cannabis products that are out there, or maybe you fancy starting your own CBD business from home, you’ll find everything you’ve been looking for over the past few months at CBD LIVE.

This virtual expo and conference is open to everyone, all around the world, and it’s totally free to register. Now that you’re here, tell a friend to go to voxpo-event.com and click the big ‘Register’ button they too will be on their way to VOXPO. Plus they could win £1,000 worth of CBD products!

HOW IS VOXPO DIFFERENT TO OTHER VIRTUAL EVENTS?

For a start, there is no registration fee. That’s right, attendance is free. With other online events, the technical capabilities for registered users and exhibitors are quite limited. Here at VOXPO visitors, speakers and exhibitors have every opportunity to engage. You can start a conversation in real time via our live Q&A sessions in the auditorium, our live

chat functionality on booths and in our LinkedIn integrated lounge for networking. And on the days that we don’t have a live event running, all of these functions will still be working, so you can drop someone a line at any time.

WHO IS VOXPO FOR?

The beauty about a virtual expo is that there are (virtually!) no limits to the benefits. VOXPO is a B2B and B2C event, offering consumers an insight into the world of CBD that they will not get anywhere else this year, due to the cancellation of physical events caused by the coronavirus. Businesses can make up for time lost over the past few months by reconnecting with contacts and making new connections, closing deals and marketing new opportunities to people around the world, all from the base of a single office desk or work-from-home set up. Education plays a key role at VOXPO, so advocates, experts and enthusiasts are also lined up to participate.

WHO IS EXHIBITING?

We have 100+ exhibitors confirmed for this, the debut event, with the biggest names across the CBD and vape industries on board from get go. We’ve been adding to our exhibitors list every day in the run up to ths weekend and we are delighted to also have great media and education partners on board too! From hemp growers to beauty brands to

manufacturers to laboratories to cannabis associations, there is no limit to the kind of businesses you can browse at VOXPO.

CAN I INTERACT WITH OTHERS IN REAL TIME?

Yes — on live days (Friday, Saturday & Sunday) you will be able to see questions from visitors and respond to them in real time. You may engage in conversations via telephone, messaging, or video conferencing.

ARE THERE ANY EDUCATIONAL RESOURCES?

Yes — education is one of the key factors taken into account by us. We are story tellers at our core. Delve into the auditorium where you will find hours of video content from CBD LIVE contributors, and our expert education partners.

CAN I ACCESS VOXPO ON MY PHONE OR TABLET?

Yes — you can access the platform from anywhere while on the go, as long as you have a good internet connection.

HOW MUCH DOES IT COST TO EXHIBIT?

We have a number of exhibitor packages available for our next three events, taking place in the next 12 months. If you would like to get involved, email info@voxpo-event. com and a member of the team can tell you more.

MEET THE EXHIBITORS

At Huna Labs , we discovered CBD when a close family member came up against serious health challenges in 2017. We quickly realised that high-strength, natural CBD was difficult to find. So, we decided to take matters into our own hands and produce our very own high-quality, 100% natural CBD. Our exceptional range of products includes a variety of different strength oils (up to 26% potency), as well topicals, patches, proteins and capsules.

A French company specialising in the B2B wholesale of phytocannabinoids, Spectrums

Europe is fully dedicated to supplying CBD specialty raw ingredients in bulk and custom made solutions based on cannabinoids. Collaborating with the most advanced analytical and evaluation laboratories in the world, we have developed unique expertise in elevating high purity CBD materials to the demanding standards of the European and Asian markets.

We manufacture CBD bath bombs alongside other CBD-infused cosmetics. CBD products have grown in popularity in recent years and we believe that the combination of this cannabinoid and essential oils has a huge range of potential benefits that are only now being fully explored. A good, long Canna Magic soak is the perfect combination of self-care and wellness that you deserve.

Huna Labs

Spectrums Europe

Cannamagic

We provide the finest, premium-grade, refined golden oil products across the UK & Europe. Our products are all-natural, organically grown in the USA, ethically sourced and third party lab tested and certified in the US and UK. Our reports guarantee that all of our THC free products are broad spectrum and packed with cannabinoids. We have a ‘complete transparency’ and ‘no nasties’ policy that ensures our entire product range is free from harmful chemicals and additives. Our products are all vegan, non-GMO, organic where possible, kosher and are never tested on animals.

Unlike CBD

We are disrupting the skincare and health industry with our five unique, vegan-friendly and all natural product ranges. We believe that the future belongs to those enlightened people that realise their own happiness, health and wellness are down to the choices that they themselves make. To be Unlike means being a little unconventional in your thinking to get a lot more happy in yourself. We’re redefining what it means to take care of yourself and your skin with the minimum of personal effort, bringing the maximum of personal difference.

The Centre for Medicinal Cannabis (CMC) Cannadle

The Centre for Medicinal Cannabis (CMC) is the UK’s first and only membership body for stakeholders in the medicinal cannabis sector operating in the cannabis-based medicinal products (CBMPs) and cannabidiol wellness markets. We have a unique capability to engage intelligently and strategically with all influential political and public policy stakeholders as well as relevant regulatory bodies. We exist to promote the sectors, both in the interest of our members and also to advance access to high quality products for patients and all those who benefit from their use.

We at Cannadle.de manufacture handmade massage candles using regional ingredients. Our candles are made of wax from local organic beekeepers and equal parts recycled paraffin and sustainably-grown stearin. For our hemp and the irresistible aroma, we work with local organic hemp farmers. Each candle contains approximately three grams of hemp flowers, 3ml of 5% CBD hemp oil and 10ml of cold-pressed organic hemp seed oil. Thanks to the handcraft and the unique blend, each candle is unique and wraps the room in a pleasantly-scented atmosphere and can be used for massages or peelings.

Hempelicious

Hempelicious is a UK supplier of premium CBD oils that have been individually blended to enhance the day-to-day lives of customers, friends and families. We passionately believe it is our duty to inform and educate on the benefits of CBD to help people maximise their potential. Hempelicious currently offers a daytime range (Ease, Relax & Uplift), as well as the Collection 7, an exclusive range of individual CBD oils with added amino acids for even greater support to health and mental wellbeing.

Cude Design

We are an expert WordPress agency specialising in website design and marketing for the cannabis and CBD oil industry. We help people set up and launch their own businesses. Our services include website design, branding, SEO and we can even help you find a payment gateway solution!

Seven Leaves is a premium botanical alternative wellness company that provides insight and education on professional CBD products. We have a long-term focus where customer interest and product quality come first. We strive to provide the best-in-class product, with people working together to bring you holistic healthy options. We have had many reports from consumers that our oil is more effective than others. We believe this is due to our unique, solvent-free extraction process and the synergistic effect of the nutrient rich CBD distillate, terpenes and other compounds found in our full spectrum industrial hemp oils.

Links Medical Products Inc. is a 25-year-old medical devices company based in Irvine, California. In 2010, LMP made an innovative move into the wound care market by developing a full range of products featuring Manuka Honey from New Zealand.

Seven Leaves CBD Links Medical Naturicious

At Naturicious , we use CO2 extraction to recover CBD and all the other cannabinoids, resulting in no pesticides or heavy metals in our products. We use a very strict process to make our products and guarantee the highest purity CBD oil on the market. The quantity of CBD and the quality of Naturicious products are guaranteed by an independent US laboratory. Our products don’t contain any THC so do not generate any psychotropic effect.

We are Insignia CBD, an award-winning CBD manufacturer and maker of the award-winning Dr Greens. We specialise in white labeling and creating CBD brands from a design in your head to a finished product on the shelves. From drops and beard oils to tattoo butters and balms, we cover just about everything and all our products are manufactured in an ISO-rated lab. We also offer wholesale for our Dr Greens brand.

Avani Botanicals

Our mission is to offer customers the highest-quality hemp extract products (CBD) at the most affordable prices. We are also actively involved in funding The Michael Seyglinski Foundation, a non-profit organisation founded by the owners of the Avani brand.

This foundation is focused on spreading early awareness about drug and alcohol addiction and educating the youth in our community, because the best way to combat addiction is to understand how dangerous and deadly these drugs can be.

B-Chill is a Swiss CBD brand producing CBD flowers and by-products like oils, cosmetics and infusions. Grown in permaculture in the middle of the Swiss Alps, our plants enjoy the best of nature: pure air, fresh alpine water straight from the glaciers and the sun of the Valais (up to 300 days a year!) Permaculture means no pesticides or industrial products, only homemade fertiliser and the help of other plants and insects!

Grass & Co. CBD is a premium range of the finest quality, ethically-sourced CBD and therapeutic botanicals. Soothe and calm the body and mind with these great-tasting CBD and botanical blends. The unique Grass & Co. EASE, CALM and REST product ranges bring balance to your day. From delicious CBD consumable oils to nourishing body oils and peaceful pillow sprays, they all work with your body to deliver uplifting results.

B-CHILL GRASS & CO Naturalrem Wellness

We provide the ultimate luxurious all-natural skincare and health and wellness products. We have a team of leading researchers and formulators from around the world who use the highest quality nutraceutical, herbal and cannabinoid-based ingredients. This attention to detail shows in all our products. Our ingredients meet the highest standards (EU-GMP), our products are natural, and our formulations are science-based. Our focus on using only the highest quality ingredients, partnered with our cutting edge, science-based formulations provides our product line with an elegance and effectiveness beyond compare.

Elixinol

At Elixinol, we’re all about you. What makes your life better, easier and just a little more amazing. That’s why we’re constantly developing new CBD products. From formats and delivery systems to unique formulations and ingredient combinations, we never stop working to create new, innovative products to fit the many needs of your ever-changing daily life. Explore our extensive collection of full-spectrum CBD oil products formulated with organic hemp extract and hemp oil. Our range includes creams, supplements, capsules and, coming soon, skincare! We are sure you’ll find the perfect blend for your needs.

CBD Credit Card Processing

CBD Credit Card Processing has merchant credit card processing solutions for all businesses in the cannabis, hemp and CBD industry. With over 10 years servicing the industry, CBD Credit Card Processing provides the best processing options available in the industry. With competitive rates, fast approvals, Fintech payment options, connectivity into all platforms, we have a solution for your business. Our team is ready to get your business set up. Contact us today!

Phytocan

Phytocan is a brand with a philosophy at its heart. We believe in delivering high end, premium cannabinoid products without the premium price tag of many CBD brands. Our CBD and CBG oils are made to our own spec in Switzerland. Every part of our oil has been grown and manufactured in-house to ensure the best quality. The plants are grown organically with no pesticides or mineral fertilisers and are tested for heavy metals. Our CBD and CBG oils are gluten-free and vegan-friendly and fully lab tested for quality assurance.

Cap Coder

British manufacturing at its finest.

A small family-run company with a laid back approach to business, we have been designing and building machines for the vape and CBD industries since their origin. Filling, capping, labelling or a totally bespoke line, from small bench top machines to completely automated high output systems, we have you covered. Come and have an informal chat and then ask our customers about us.

Simplifying the world of CBD

Hempelicious is a UK CBD company created to help ‘simplify the world of CBD’. Our online range of high-quality, premium CBD products have been individually blended to support positive health and mental wellbeing.

Ethically sourced and 100% organic, every Hempelicious CBD product has been rigorously lab tested in the UK for both quality and consistency.

CUBID CBD

CUBID CBD offers a high performance, superior quality CBD solution that stands in a league of its own. Our CBD products combine the world’s finest industrial hemp-derived CBD, natural botanicals and essential oils to deliver a cutting-edge and effective CBD skincare range accessible to all. Our products are manufactured in the UK, sourcing the finest quality THC-free CBD and ultimately helping our customers to #ChooseaBetterDay everyday. Our products are stocked by Holland & Barrett, Cult Beauty, All Beauty, Ocado among others.

The CANNAVIST

Welcome to CBD LIVE , our first event which we have organised from start to finish. The driving force behind this concept from the get go has been education, in lime with what we do day-to-day with the magazine. So as your hosts for the weekend, we invite you to expand your horizons, start conversations and ask questions. Stop by our booth in the CBD LIVE Hall and subscribe to our magazine to get your first issue free! Got a question about the VOXPO platform, email info@voxpo-event.com and a member of the team will get back to you. We hope you enjoy this virtual event presented by The CANNAVIST.

Health CBD

Health CBD was founded back in 2018 by a group of health-conscious hemp aficionados. We are proud to offer all-natural, organic CBD products and we are committed to bringing our customers the highest grade CBD products. Manufactured in our state-of-the-art, ISO Class 7 cleanroom facility, we further send our products for third party laboratory testing for microbial, heavy metals and cannabinoids testing. We believe we are indebted to our customers and we work hard to keep their trust!

The Association for the Cannabinoid Industry

The Association for the Cannabinoid Industry, The ACI, is a membership organisation committed to nurturing a safe, legal and well regulated CBD market in the UK. Our vision is to create an innovative, sustainable sector that meets the highest standards in product quality, consumer satisfaction and environmental stewardship. Don’t miss our four panel discussions in the CBD LIVE Auditorium across the weekend!

Dollar a day CBD

We are Dollar-a-Day CBD, a subscription-based CBD oil company that stands out by only selling the most premium product at one of the most affordable prices on the market. Our mission is dictated by the core belief that CBD should be accessible to everyone, regardless of economic class or financial position. Unlike big pharma or opposing CBD giants with investors to answer to, and multi-level marketing companies, we put our customer’s well-being before our profits.

Perry Johnson Laboratory Accreditation

PJLA is a third-party accreditation body offering ISO 17025 testing and calibration laboratories globally. We serve various industries and also accredit sampling and inspection organisations to ISO-based standards specific to national requirements. We are recognised by the International Laboratory Accreditation Cooperation (ILAC) and by the Asia Pacific Accreditation Cooperation (APAC) as an ISO 17011 compliance accrediting organisation and we are recognised worldwide for our services. We strive to ensure customers succeed in becoming accredited as efficiently as possible by providing quick turnaround times on assessments, customer inquiries and certificate release. Don’t miss our segment in the CBD LIVE Auditorium from 3pm on Friday!

CBD Luxe

We want you to BE Your Best. The best is what we give you at CBD LUXE. The best Colorado Department of Agriculture-certified hemp. The best USDA-certified organic, non-GMO ingredients, manufactured in the best GMP-certified facility. We provide the best, most advanced formulas and delivery systems for whatever your CBD needs. Because at CBD LUXE we believe you are the best!

CBD-Intel

CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking and quantitative data for the cannabidiol sector, with a focus on non-US markets. We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions. In addition, we offer customised research and consultancy support. Don’t miss our segment in the CBD LIVE Auditorium, Friday from 11am.

Jupiter Research is the leading provider of performance-driven wholesale vaporizer cartridges and power supplies. Based in the US with over 800 partners around the globe, Jupiter is the industry standard brands turn to. Jupiter’s line of products is specifically engineered for CBD and THC plant-derived oils and Powered by CCELL® technology. As a renowned global leader, Jupiter Research is the preferred choice for wholesale and custom vaporizer hardware.

Jupiter Research Cannhelp

Cannhelp is a biotech company and specialised manufacturer of high-quality hemp products. As an Austrian pioneer, since our foundation in 2015, we have focused on the best quality, fair prices and the de-stigmatisation of cannabis and hemp. We set ourselves the goal of offering high-quality hemp extracts through gentle CO2 extraction at fair prices, thereby making the versatile effectiveness of hemp available to as many people as possible.

Vapour District

We are a Latin American company with an international focus on the distribution of vaping products. We travel around the world to be at the forefront, offering customers a high end portfolio and creating innovation in the market.

RVD CBD

Since day one, our goal at RVD CBD has been to produce the highest quality CBD/hemp products using the state-of-the-art production methods and manufacturing practices, to help others live physically and mentally pain-free. Don’t miss our founder and wrestling sensation Rob Van Dam in the CBD LIVE Auditorium, Sunday from 3pm.

Women Empowered in Cannabis

WEiC is a community of women working in cannabis, hemp & CBD. Our members are executives, entrepreneurs, professionals, politicians, activists, influencers and community leaders. We share resources, provide support and build networks around the world with women who are part of a movement to create an inclusive, diverse and equitable cannabis industry. We believe together women create a strong community, impact policy and create solutions to the industry’s biggest issues. #bettertogether

Budcoin

R&R Naturals, one of the top providers of high quality full spectrum CBD, is proud to introduce the Budcoin. Budcoin is the first cryptocurrency asset-based token that can be used as a payment option for purchasing CBD products. The Budcoin will be an alternative to traditional based currencies. This is significant because for some time now traditional CC processing has been somewhat of a challenge for the CBD industry.

Sovereign Fields & Humboldt Seeds

Sovereign Fields’ CBD and CBG-rich varieties are reshaping the future of hemp in the US and international hemp marketplace. Sprouted in Humboldt County, our leaders have 20 years of industry experience and strategic partnerships. With cutting edge science-based research and development, Sovereign Fields is expanding the boundaries of what’s possible. With over 30 million seeds sold, Sovereign Fields is your trusted source for top quality hemp genetics.

CanXchange

Our team is driven to support our peers by sharing a wealth of trading, technology, client services and industry knowledge. We have created an innovative and user-friendly platform to provide our members with the first physical hemp trading destination of its kind. CanXchange not only allows buyers and sellers to transact and negotiate but it also aims to regulate the industry by offering fair pricing and ultimate transactional security in which we recognise has been a long-term challenge.

Nestlé

With cannabidiol (CBD) becoming one of the biggest trends in the food industry, ensuring quality results is critical for your business. At the NESTLÉ QUALITY ASSURANCE CENTER IN DUBLIN, OHIO, OUR METHODOLOGY ALLOWS FOR THE QUANTITATIVE DETERMINATION OF 14 CANNABINOIDS COMMONLY FOUND IN HEMP PLANT, OIL, AND OIL CONCENTRATE PRODUCTS USING LIQUID CHROMATOGRAPHY TANDEM MASS SPECTROSCOPY (LC-MS/MS).

InstaPür CBD is a purely organic oil, without the addition of harmful ingredients, developed and patented under a unique manufacturing process, which disrupts cannabinoid molecules in nanoparticles. This process allows our oil to become 10 times more powerful than any oil on the market. Our NANO tincture contains 37.5mg / ml. This implies that, when you get the InstaPür CBD tincture, you are receiving 37,500,000 nanograms / ml in our container made specifically to facilitate your dose and treatment. Made in the USA. InstaPür CBD is a brand distributed by ECPR Corp. & imported by Caribbean Botanicals Distributors Inc.

We have spent a lot of time working on our brand to create something that from seed to bottle is the highest quality. From looking for the perfect farm with the best practices to processing that is about the perfect CBD product rather than creating another fad to intrigue the masses. We got rid of all the unnecessary variants and came up with a simple product line that had something to suit everyone. Third party testy, quality assured and we offer a 30-day money back guarantee.

We are cannabis vaporization solution experts, created by our mother company First Union. Our love for innovation never ceases. Living by our values, innovation, win-win and professionalism, our vision is to invent great vape hardware and change people’s lives. Just like what we expressed in our slogan Beyond Vapor, apart from premier products, we also provide a one-stop seamless service and sustainable relationship.

InstaPür CBD Planthaya Deep Union Agrowth Corp

Your one-stop shop for hemp cigarette contract manufacturing, hemp processing and co-packing. From raw material sourcing, packaging design and production, material blending and formulation, scaled production, retail packaging, and testing & assurance, we can help you develop and produce the right product fit for your brand’s vision.

MEET OUR EXPERT SPEAKERS

Landa

Dr Elisabeth Philipps

Boaz ‘Bobo’ Lehman is a man of the wild. His relationship with plant medicine started in 2009 in the Himalayan mountains where he absorbed the knowledge of the locals. After witnessing the power of plants first-hand, Boaz travelled the world gaining a wealth of first-hand ethnobotanical knowledge about all types of plants. After completing his training in a variety of natural therapy methods, he started formulating remedies for both patients and therapists. Driven by a belief in the importance of respecting and connecting with nature, Boaz makes all of his remedies using plants he has foraged according to season, location, moon cycles, and local traditions.

“Natural therapy by necessity must be holistic, and it looks at the person as a whole, from his/her relation to him/her self all the way to the environment.”

“Self-help is key to health but changing our lives and habits to a healthier lifestyle is hard, and we all could use some help.”

Passionate about plant-based remedies, holistic health specialists Oren & Boaz join the editor of The CANNAVIST in discussing how CBD and medical cannabis may be beneficial in managing anxiety, sleep, depression and stress.

Dr Elisabeth Philipps is a neuroscientist and is one of the UK’s leading experts in hemp, phytocannabinoids and the endocannabinoid system. She speaks nationally about CBD and the ECS at conferences and clinical education events and provides expert opinion and content for the national press, specialist healthcare publications and health companies. Dr Elisabeth is also passionate about health and wellness education and created NutriHub.org, an online nutrition and lifestyle training platform. Elisabeth’s extensive academic training includes a BSc (Hons) in Biomedical Science from Kings College London, a PhD in neuropharmacology from Oxford University and a BSc in Nutritional Medicine alongside an Institute of Functional Medicine certification.

Boaz Lehman Integrative Clinical Herbalist. Head of R&D at Kiara Naturals.

Oren

Osteopath & Naturopath. Co-founder & CEO at Kiara Naturals.

Clinical Neuroscientist.

Maria Alejandra Estanga Market Analyst, CBD-Intel

Alejandra graduated as an economist at the Andrés Bello Catholic University in Caracas, Venezuela and has a master’s degree in marketing from the UPF Barcelona School of Management. She has worked as an analyst at Nielsen and also has experience as a sales analyst for Henkel and Volkswagen. As a member of CBD-Intel’s market research team, Alejandra is involved in analysing the European and American CBD markets.

Tara

Tara is an East London-based yoga practitioner and experienced circus performer. Tara has been practicing yoga for eight years and teaching for three years. Her practice began through Ashtanga, and has evolved to encompass aspects of Kundalini, Hatha, and Yin. Her work as a performer and artist is intricately tied to her yoga and meditation practices. Her purpose is to help others access their creative energy and connect with their bodies through movement meditation.

Brett McMillen Cannabis/Hemp Division Manager at Perry Johnson Laboratory Accreditation, Inc

Brett McMillen has been the Cannabis/Hemp Division Manager for Perry Johnson Laboratory Accreditation (PJLA), a private third-party accreditation body located in Troy, Michigan for the past 11 years. Brett manages PJLA’s sales team and assists with business development and marketing. Brett participates with several hemp and cannabis industry groups as well as state regulatory initiatives. Brett largely contributes to PJLA’s growth by onboarding new customers and managing a large customer base. He also contributes to other Perry Johnson companies that provide quality management certification such as ISO 9001, GFSI standards, GMP, and HACCP. Prior to his long term profile with Perry Johnson, Brett was a business owner and sales manager for multiple companies. Brett holds a BA in History and Microbiology from Ohio Wesleyan University.

Kearney Meditation Guide Rosie Underwood Editor, health coach & yoga specialist

Rosie is a teacher and specialist in Vinyasa flow with Positive Psychology. She used yoga as a way to keep her grounded in her work as a magazine editor. Her fascination and increasing interest in yoga and meditation led her to practice in all four corners of the globe, and after eight years of dedication to learning, she made the jump to teaching. Rosie’s uplifting and energetic sequences are tailored to suit each student’s ability, energy levels and mindsets from a bio-individual standpoint. Weaving positive psychology and mantras into her classes, Rosie sets the tone for gaining strength, mobility and resilience both physically and mentally, keeping students fully immersed. Rosie’s work as a wellness journalist and integrative health coach means her knowledge and understanding of marrying a healthy mind with a healthy body comes part and parcel with her teaching.

Jessica Steinberg

Co-founder of the entOURage Network & Head of Community at Ohana CBD

Jessica is a PhD student at the University of Oxford exploring the process of policymaking through the lens of cannabis legalisation. She is managing director of international cannabis consultancy, The Global C, and co-founder of a women’s empowerment organisation cultivating a space for women in the legal cannabis industry, the entOURage Network. Jessica is also head of community at Ohana CBD, a plant-based self-care skincare company. Her policy work takes place as an official delegate for cannabis related meetings held at the UN and WHO. She speaks globally about her research and work, as well as the charity that she founded when she was 13, Giveable Giggles.

Dr Dani Gordon, MD CCFP ABOIM ABIHM

Author of ‘The CBD Bible’

Dr Dani is a double board-certified medical doctor, integrative medicine physician and world leading expert in CBD, cannabis medicine, brain wellness and stress resilience. She was one of the youngest physicians to become American board certified in integrative medicine (the newest US physician subspecialty). She also co-founded the UK Medical Cannabis Clinician’s Society (MCCS), trained the UK’s first cannabis medicine specialists and helped set up the UK’s first cannabis medicine centres. She has lectured at Imperial College, King’s College, and UCL on medical cannabis. She is a published researcher and her book ‘THE CBD BIBLE’ was published in July.

Dr Dani will host a LIVE Q&A on Saturday, August 1 from 2pm in the CBD LIVE Auditorium.

Rob Van Dam

Wrestling

icon & CBD entrepreneur

Say it with us now, Rob! Van! Dam! One of the most recognisable names and faces in the global wrestling arena, Rob Van Dam has set his sights on the title of CBD heavyweight in launching his own range of products, RVD CBD. The professional wrestling icon is passionate about helping fellow athletes navigate the consequences of a lifetime in impact sports, where the very real and often fatal consequences of sustained concussion may lead to a brain disease called CTE later in life.

Rob Van Dam joins neuroscientist Dr Elisabeth Philipps and George Kruis of Saracens Rugby / fourfive CBD to discuss CBD use in sporting circles, the injuries we can and can’t see on Sunday from 3pm in the CBD LIVE Auditorium.

Cannabis

& TV Chef Melissa J Parks

As seen on NETFLIX & The FOOD NETWORK!

An experienced cannabis chef, CBD consultant and edible developer, Chef Melissa loves to cook with cannabis. So much so that she was a contestant in episode two of Netflix series ‘Cooked with Cannabis’. She has also been featured by the Food Network on US television hit ‘Chopped’. In a special cooking demo for CBD LIVE at VOXPO, the Cordon Bleu-trained chef will give an insight into the dos and don’ts when cooking with CBD, including tips on dosage and flavour.

Check out the CBD LIVE Cooking Theatre on Saturday at noon!

George Kruis

Rugby player & co-founder of fourfive CBD

George Kruis has 12 years of experience as a professional rugby player. His love for rugby and his exceptional skills have led him to gain two European titles, and three Premiership trophies. When he’s not on the pitch, George and former teammate Dominic Day work side-by-side on fourfive CBD. The co-founders created the brand out of their own experiences with injuries and have made a zero-THC formula to give fellow athletes peace of mind when taking CBD.

George joins The CANNAVIST at CBD LIVE to discuss his discovery of CBD while recovering from injury, and his brand journey with former Wales rugby international Dominic Day.

Jorge Rubio Escalona

External advisor to the Mexican Senate

Formerly the Chief of Staff of the Public Health Institute and Social Services to the Mexican Federal Government, Jorge now lives in Vancouver, Canada and is both an entrepreneur and a cannabis industry marketing specialist with experience in sales, drug development and education. As an external advisor to the Mexican Senate, Jorge is an expert in Mexican government relations and has first-hand knowledge of Mexico’s pathway to cannabis legalisation.

Kyra Reed

Founder of Women Empowered in Cannabis

Kyra Reed is the founder of MarKyr Media and is also at the helm of Women Empowered in Cannabis. WEiC started as a facebook group, connecting women from various backgrounds and skillsets, each sharing advice and pointers on how to succeed in the cannabis industry. Today, WEiC is a cross-platform community of thousands of women including influencers, CEOs, entrepreneurs and employees who share resources, provide support and build networks around the world with females who work in cannabis. California-based Kyra has been credited as being ‘a social media pioneer’. Kyra joins the editor of The CANNAVIST Róisín Delaney and Jessica Steinberg, co-founder of the entOURage Network, to discuss the impact women have on the cannabis market. Kyra says: “We need to stop apologising for being women!”

Kristina Spionjak Marketing Director, London Canna Group

Kristina is a PR and marketing consultant with over a decade of experience, working with a wide variety of lifestyle, CBD, medical cannabis, beauty, sports, and fashion brands in the UK. With experience at all stages of the concept-to-sale-journey, Kristina has been helping business minds develop their ideas, find primary suppliers, develop relationships with perfect manufacturing/production partners and to ‘tell their story’ to the people who matter in the most compelling, distinct and relevant manner. Her clients have been featured in top media outlets such as the BBC, TimeOut London, Elle, Brides, Vogue Paris, BBC Radio, The Guardian, FT, Tatler, Wedding Ideas, You&Your Wedding, among others.

Housam Nasr Co-founder of London Canna Group

Housam is serial entrepreneur and co-founder of London CBD Group, a comprehensive consultancy that helps entrepreneurs start, run, and grow their cannabis businesses through consulting, retail, and e-commerce. Nasr has a wealth of experience across all areas of setting up a business in the CBD industry – from inception, strategy, sales, operations, finance, marketing, product development, wholesale, distribution, retail operations.

He has successfully co-started two retail stores in London, Code Vape and Canna Club Shoreditch. Housam has valuable lessons to share about negotiating the pitfalls, transparency, customer relationships, maximising the opportunities, and having the resilience to see it through.

Dr Parveen Bhatarah, PhD, FRSC

Regulatory and Compliance Lead, Centre for Medicinal Cannabis. Director, Regulatory & Compliance Unit at the Association for the Cannabinoid Industry.

Dr Parveen completed her PhD in organic chemistry from Imperial College London and is a fellow of the Royal Society of Chemistry. She has held various directorship roles in the generic and herbal pharmaceutical industry with over 20 years of expertise in bulk drug substance and product development including clinical trials, commercial launches, technology transfers and manufacture for ANDA & MA submissions. She has developed several innovative technologies in pharmaceutical field which is clear from her patents. She has worked closely with various international health authorities on numerous commercial generic pharmaceutical and herbal pharmaceutical product launches and submissions. Most recently, in the cannabis space she was instrumental in the THC project for seed to capsule development, passing pre-approval inspection by US-FDA. Join Dr Parveen across the weekend as she chairs significant industry development discussions with members of The Association for the Cannabinoid Industry and The Centre for Medicinal Cannabis at CBD LIVE.

Marc Burbidge Development and Quality Lead at the Association for the Cannabinoid Industry

Marc has spent the past 10 years studying holistic medicines, cannabinoids and manufacturing. More recently Marc has consulted for some of the largest CBD manufacturing companies in the UK. His far-ranging experience covers plant genetics, cultivation, extraction, product development and mass manufacturing as well as the legislative and compliance aspects of the industry. Marc is a regular on the CBD speaking circuit, notably covering the CBD as a novel food topic.

Isabel Alber

Food Scientist & Regulatory and Compliance Consultant at the Association for the Cannabinoid Industry.

Isabel is a food scientist with 25 years of experience in the food industry in all sectors and continents. Isabel specialises in Food Safety and Quality Management Systems [ISO 9001, FSSC 22000, BRC, IFS], both in certification as an international third-party auditor and as a consultant in the UK and Spain, helping companies implement international standards and retailer codes of practice. She also has a broad experience of delivering training courses.

Shomi Malik Development Director at the Association for the Cannabinoid Industry

Shomi is an entrepreneur who has worked across multiple sectors in Europe and Asia. He moved into the cannabinoid space two years ago after having experienced first-hand how beneficial these readily available products could be and has since focused his efforts in bringing quality standards to the industry. He was instrumental in setting up the Cannabinoid Trust, a not-for-profit organisation assisting many companies with product testing.

Rosemary Mazanet Columbia Care. MD, PhD.

Rosemary began advising Columbia Care in 2013. She joined the Scientific Advisory Board as its chair in 2015 and became its Chief Scientific Officer in 2017. Rosemary trained in Internal Medicine and Oncology at the Brigham and Women’s Hospital/Dana Farber Cancer Institute before starting her industry career at Amgen in the early 1990s as the head of clinical research. Rosemary has been a presence in public and private equity biotech and specialty pharma investments, most recently as a General Partner of Apelles Investment Management. In addition to serving as a life sciences management and investment professional, Rosemary has served as a C-suite executive at several biopharma companies and led development programs ranging from IND submission through NDA approval and commercial launch. Among the many boards she is on, Rosemary is a Charter Trustee at the University of Pennsylvania School of Medicine and is the co-chair of the Leonard Davis Institute Executive Advisory Board at Wharton.

Bill Griffin

Cannabis Journalist, advocate and Media Lead at the Association for the Cannabinoid Industry

Bill writes about cannabis in Europe and has more than 20 years of experience working in corporate communications. In his previous life he worked for SWIFT, Comcast and consulted for British Airways, IBM and other blue-chip companies. Back in 2007, Bill had a medical need for cannabis but had no safe supply. After gaining knowledge of cannabis he set about sharing it with others using his communications skillset. He writes about his experiences and the emerging European cannabis industry. As a freelance expert Bill has supported various organisations within the medicinal cannabis and wellness sectors, is on the Advisory Board of Cannabis Patients Advocacy Support Service (CPASS) and is Managing Director of the CBD brand LXR. He has also worked as a research analyst for New Frontier Data.

Kamila Laura Sitwell Co-founder,

Kolibri Drinks

Kamila is the co-founder of Kolibri Drinks, the world’s first packaged drinks which empower consumers with personalisation of flavours and dosing of ingredients such as CBD. Kamila and her team are on a mission to create brands of the future in proprietary, eco-friendly packaging which enables personalisation, dosing and effective supplementing – imperative for the cannabis industry. Kolibri is the UK’s most awarded beverage innovation of 2019 pioneering experiential drinks which inspire, heal and delight. Kamila is an award-winning professional with more than 20 years of experience in the beverage industry, F&B blogger with over 100,000 followers, and the author of the Amazon bestseller ‘Bespoke’.

Joe

Seaman Head

of Regulatory Compliance, CBD Capital

Joe has worked alongside industry experts and leading medical practitioners within the cannabis sector, which began during his time living in California. Whilst there, he researched the medicinal potential of cannabis, as well as how cannabis companies can effectively navigate this fast moving, global industry. Upon returning from America, Joe proceeded to work alongside UK CBD and cannabis companies in content marketing & strategy and helped form an independent CBD & Hemp Trade Body. Joe is now Chief Product Officer of Cannyx Markets, a blockchain backed cannabis & hemp online trading platform and Head of Regulatory Compliance for CBD-Capital, a UK-based B2B CBD raw material distributor.

Moyra Cosgrove Head of Nutrition, Naturecan

Moyra Cosgrove has worked in the nutrition, health and pharmaceutical industries for all of her professional life. She holds a BSc Hons in Human Nutrition from the University of Greenwich and completed MSc in Sport Nutrition in 2016 at Liverpool John Moore’s University.Moyra’s experience spans the Nutritional Supplement Industry, the Medical Nutrition Industry and she has appeared on BBC and Sky News on many occasions. She is passionate about emerging nutraceuticals, including novel foods, focussing on evidence-based nutrition. Moyra is a sports enthusiast, a supporter of LFC, a keen tennis player and an avid follower of the professional tennis tours. Moyra is interested in exploring the increasing use of CBD in sports and in consumer health. She will soon begin studying for her Professional Doctorate in Sport Nutrition, with a research focus on CBD. Moyra currently works for Naturecan, on the Novel Food application and other Nutrition projects.

Joseph Colliver CFO, Sativa Group

Joseph is a Chartered Accountant with a track record in financial and statutory reporting, strategy, commercial finance, management consultancy and regulatory compliance. Joseph is accountable for the financial, statutory and regulatory reporting associated with a publicly listed company and performs a group leadership role as one of two executive board directors. Joseph has worked across the health and wellness, consumer goods, retail, marketing, market research and financial services sectors. Previously a director of consulting at Kantar Consulting, part of WPP Plc (WPP) which advises retail, sales and shopper clients on enhancing their commercial capability and the commercial competency of their staff. Joseph was also CFO and a senior board member at WPP’s Kantar Futures.

From 2012 – 2015 Joseph was Global Commercial Director of WPP’s Kantar subsidiary Taylor Nelson Sofres, a $1.8 billion turnover marketing agency.

Angus Taylor CEO, Infused Products International

Angus Taylor is the CEO of Infused Products International (IPI) and founder of NewLeaf, one of Canada’s most successful retail brands to date. As an entrepreneur in a variety of industries with a focus on business development, strategy, innovation and new market identification, Angus became passionate about the cannabis industry in 2015. Since that time he has worked with both local and international business to help them understand and strategise the best paths to success within this incredibly competitive landscape.

Nick Pateras

Managing Director for Europe, Materia Ventures

Nick Pateras oversees commercial strategy and operations at Materia Ventures, a manufacturer and distributor of medical cannabis and CBD products across the burgeoning European market. Previously, Nick served as Vice President of Strategy at Lift & Co., Canada’s leading cannabis education and insights platform. An early stage employee, he helped scale the company to over 60 people, including a go-public transaction on the TSXV and securing numerous government contracts. He is a regular speaker at cannabis conferences across North America and Europe and taught the Cannabis Business Fundamentals course at George Brown College in Toronto in 2018-19. Prior to his time in cannabis, Nick spent several years in the pharmaceutical sector with Johnson & Johnson Inc, managing various category-leading OTC and Health & Beauty businesses. His background in healthcare led him to make the professional move into cannabis, having long advocated for recognition of its many medical applications.

Haseeb Bani

Director of Research and Development, B3 Supplements

Having a chemistry background allied to in-depth analytical expertise, Haseeb has played a key role in the design and development of the comprehensive line of CBD products available at B3 Labs. His keen eye for detail and precision are invaluable as director in his field. In his role, he is responsible for the creation of new and innovative product lines by mapping out the trends in the health and wellness space, leading the production teams and setting the analytical testing processes or all products as they head to market, while also overseeing B3’s push to obtain the global standard of certifications.

Filipp Korentsvit

Co-founder, WeedWorks

Filipp is the co-founder and co-CEO of WeedWorks, a company working towards delivering the wisdom of the cannabis plant to the people. Prior to WeedWorks, Filipp spent most of his adult life working in the financial sector and as an entrepreneur engaged in emerging markets

Len May Co-founder EndoCanna Health & CBDIA board member

Len is CEO and co-founder of EndoCanna Health, a bioscience research company specialising in personalised medicinal cannabis using DNA sequencing, and parent company of the EndoCanna Health DNA Test Kit. With over 25 years of experience, Len is a pioneer in the medical cannabis industry having held positions such as the President of the Cannabis Action Network, Board Member and Lifetime Member of California Cannabis Association, as well as being a stakeholder in some of the industry’s most iconic brands. His experience also encompasses a strong understanding of branding and compliance, fundraising, and operations. Len is also a Certified Medical Cannabis Specialist in Medicinal Genomics.

Priscilla Agoncillo

Co-founder Original Breeders League & President of the CBDIA

Priscilla P. Agoncillo is a passionate advocate and prominent business advisor serving the cannabinoid industry for over 15 years. Priscilla has brought the expertise of business strategy, branding, and business development to the cannabinoid industry formally being from banking and private equity, sales and entertainment. Priscilla has appeared countless times as a public speaker for patient rights, law reform, and cannabis business insight in various newspapers, on television, radio programmes, and at industry conferences. She is co-owner of OBL Biodynamic Farms, a multi-award-winning licensed cannabinoid breeding farm and co-founder of the Original Breeders League, an organisation created to gather top-performing cannabinoid breeders from around the world.

SPEAKERS

Johnson

SPEAKERS SCHEDUL E

10:30AM 12:00PM 2:00PM 3:00PM 4:00PM 5:00PM

Live Virtual CBD Yoga

Welcome to the CBD Live Cooking Theatre!

CBD, medical cannabis & women’s health with world leading expert Dr Dani Gordon

The ACI: Everything you wanted to know about CBD but didn’t like to ask

Rosie Underwood, editor, health coach and yoga specialist

TV Cannabis Chef Melissa J Parks from the Netflix series ‘Cooked with Cannabis’. As seen on THE FOOD NETWORK

Presented by Dr Dani Gordon, MD, CCFP, ABOIM, ABIHM. Author of the recently published book, ‘The CBD Bible.’

Chaired by Bill Griffin, Media Lead, The ACI. Featuring ACI members: Haseeb Bani, Director of Research and Development, B3 Labs; Joseph Colliver, CFO, Sativa Group and Moyra Cosgrove, Head of Nutrition, Naturecan

Paving the way towards cannabis legalisation. The steps a nation must take, looking at the Mexico and Canada examples

The power of plant extracts in modern medicine. CBD for mental health; with naturopath, osteopath and clinical analysis

Jorge Rubio Escalona, external advisor to the Mexican Senate & cannabis consultant Chaired by Róisín Delaney , Editor of The CANNAVIST. Featuing Boaz Lehman & Oren Landa of Kiara Naturals

SPEAKERS SCHEDUL E

11:00AM 12:00PM 1:00PM 3:00PM 4:00PM

Sunday August 2

Welcome to CBD LIVE Guided Meditation

The impact women have on the legal cannabis industry and overcoming barriers to success

The ACI: The future of cannabinoids. Future innovations in the cannabinoid Industry

Tara Kearney, Meditation Guide

Chaired by Róisí n Delaney, Editor of The CANNAVIST. Featuring Kyra Reed of the WEiC and Jessica Steinberg of the entOURage Network

Chaired by Marc Burbidge, Development and Quality Lead, The ACI. Featuring Dr Parveen Bhatarah, Regulatory and Compliance Lead, The ACI; Filipp Korentsvit, co-founder and co-CEO, Weedworks; Rosemary Mazanet, CSO Columbia Care; Nick Pateras, MD for Europe, Materia Ventures and Angus Taylor, CEO, Infused Products International

CBD in sporting circles. The injuries we can and can’t see

Chaired by Róisín Delaney, Editor of The CANNAVIST. Featuring Dr Elisabeth Philipps, Clinical Neuroscientist; George Kruis professional rugby player & cofounder of fourfivecbd.

The Resu lt s AWARDS

Also featuring wrestling sensation Rob Van Dam, founder of RVDCBD

Don’t Miss! Exclusive Giveaways

1. The CANNAVIST is giving away £1,000 worth of CBD products!

Join the CBD LIVE leader board competition and earn points as you go. Collect as many points as you can from all activities available through VOXPO and on Sunday you could be the lucky winner of £1,000 worth of CBD products.

2. Tell a friend to register for VOXPO and they could be in with a chance of winning £1,000 worth of CBD products. Everyone who registers on voxpo-event.com will automatically go into the draw.

Discover more competitions on the circuit as you browse more than 100 VOXPO booths.

THE CANNAVIST

Stop by our virtual expo stand and chat with the makers of the magazine. Have a story idea? Or maybe you’d like to submit a product for review. Now is your chance to chat oneon-one with the editor of the UK’s first cannabis publication, the only magazine of its kind on sale on the high street.

AS SEEN ON THE TELLY

One of our CBD exhibitors is making their TV debut this week! UNLIKE CBD will appear on popular teleshopping channel Ideal World: idealworld.tv, and the brand is also being featured on ITV’s Ideal World slot from midnight to 3am.

Virtual expo booths you simply MUST visit!

HUNA LABS

With a master CBD blender with over 30 years’ expertise at the helm, Huna Labs is fast becoming one of the UK’s most popular CBD brands.

INSTAPÜR

Coming to us from Puerto Rico, InstaPür utilises nano-technology to offer brands top notch CBD solutions by increasing bioavailability up to 90%.

RVD CBD

Wrestling icon and long-time cannabis advocate Rob Van Dam is here with a bang. Check out the RVD CBD virtual booth for excellent quality products all the way from Nevada. Are you a fan? Don’t miss Rob Van Dam in the CBD LIVE auditorium, Sunday from 3pm.

CBD LUXE

Because even your CBD should be a little luxe

SPECTRUMS EUROPE

Based in France, Spectrums Europe has emerged as a strong contender in the race for Europe’s leading raw material supplier. Stop by the stand if you are interested in developing a new CBD product. The team at Spectrums are experts in sourcing everything from isolate to innovative water-soluble CBD.

THE ASSOCIATION FOR THE CANNABINOID INDUSTRY & CENTRE FOR MEDICINAL CANNABIS

The sister organisations will occupy one virtual booth with the mission to spread accurate information and advice on topics like the FSA regulations and product safety. In retail? This is an essential stop for you. Don’t miss the ACI and CMC in action in the CBD LIVE auditorium across the weekend.

Not just a machine, but an entire manufacturing process

Agrowth Corp is your One Stop Shop for hemp cigarette contract manufacturing, processing, and co-packing. From raw material sourcing, packaging design and production, material blending and formulation, scaled production, retail packaging, and testing & assurance, we can help you develop and produce the right product fit for your brand's vision.

CBD LIVE AWARDS

We are really excited to be able to present something truly special during what has been a challenging time for everyone. Thanks so much for giving up your time and joining us online.

In the spirit of positivity and celebration, we look forward to honouring the first CBD LIVE award-winners chosen by you, the public and readers of The CANNAVIST. The winner of each category will receive a coveted CBD Live award. So whether you’ve been wowed by a product at VOXPO or just want to support your favourite brands, vote now to have your say.

Voting closes Saturday night!

The winners will be announced in the CBD LIVE Auditorium on August 2.

Here are the categories:

• Best Tincture

• Best Topical

• Best Edible

• Best Vape

• Best Overall Product

The countdown is on.

Voting closes at 23.59 on August 1.

AS SEEN IN THE CANNAVIST

Here’s a taster of what kind of content you can expect from the new issue of The CANNAVIST

WHEN THE FUNDRAISING ENDS…

Lockdown has had a huge impact on millions of lives around the country. Millions of pounds have been raised in tear-jerking stories that have captured the heart of the nation.

But for the children who rely on fundraising to support their private medical cannabis prescriptions, it has had truly life-threatening implications, as The CANNAVIST’s Gordon Stribling has found.

WORLD’S FIRST CANNABIS TRIAL INVOLVING A BABY BEGINS IN LONDON

The world’s first cannabis-based medicine trial involving newborn babies is underway in the UK. A research team led by Guy’s and St. Thomas’ NHS Foundation Trust in London hopes it will help infants who are at risk of developing brain injuries or suffering from seizures.

NETFLIX AND…CBD? SUMMER SKIN

‘Milkshake’ singer Kelis brings her new ‘Cooked with Cannabis’ show to Netflix, but what is her connection to CBD? In this interview, The CANNAVIST gets a glimpse into her on-screen kitchen and we meet a contestant from the show.

The timing of this new Netflix show could not have been better. It was released on 4/20 during a lockdown that has seen sales of cannabis (in legal capacities) and CBD rising. The show is hosted by the singer. And yes, she could teach you, but she’d have to charge. (If you know, you know!)

CBD has infiltrated high street beauty brands with familiar names like Nyx, Nails Inc. and Make Up Revolution launching CBD-infused must-haves that will probably wind up in our make-up bags, because who doesn’t love something new and now. (Hands up if you’re a beauty marketer’s dream like us!)

From SPF to antioxidants, we uncover what we should all be rubbing on our faces this summer and CBD is definitely on the list!

MODERN SOLUTIONS FOR A MODERN LIFESTYLE

The safety of vaporizer products is of the utmost impor tance. Jupiter Research is proud to be a distributor and manufacturer of vaporization technology hardware that is manufactured in facilities compliant with the highest safety and quality standards. Learn more at JupiterResearch.com

Terpene-rich

EXTRACT

A collection of CBD and medical cannabis headlines from close to home and around the world. For these stories and more, subscribe to The CANNAVIST!

White House Submissions

In late July, FDA officials submitted a draft CBD enforcement paper to the White House, signalling that CBD regulation may be on the horizon after lengthy anticipation. The CANNAVIST understands the US FDA Cannabidiol Enforcement Policy Draft Guidance for Industry was received by the White House Office of Management and Budget for consideration. That office must now take the draft proposal under consideration, examine it and make a recommendation for approval. If approved, the US CBD market could see steps to regulation revealed in the very near future. FDA officials have been busy working on cannabis in recent months as in the days leading up to this CBD submission, another draft was submitted to the White House, this time pertaining to clinical research where cannabis-derived drugs are concerned.

Three tiers

The Association for the Cannabinoid Industry (ACI) recently launched a safety certification initiative as it readies members for the Food Standards Agency’s (FSA) novel foods deadline. The ACI certification programme provides a three-tiered route towards compliance, starting with an audit and ending with full novel foods authorisation.The ACI believes the process will ‘bring a level of trust to the industry that until now has been lacking.’ ACI Pharmacy Lead, Dr Andy Yates, says consumer confidence in CBD is lacking: “It’s been clear that retailers and consumers don’t have complete faith in CBD products that are currently for sale in the UK. The ACI certification is a simple way for retailers and consumers to be sure that the CBD products they are stocking or buying are complying with or working towards all of the relevant regulations.”

Mystery Shopper?

Uruguay, the first country to legalise cannabis, has been exporting what are reportedly some of the largest ever transatlantic shipments of cannabis flower to at least one mystery buyer in Europe. The South American nation legalised cannabis in 2013. At the end of 2019, a 1,000kg shipment of high-THC cannabis flower was legally exported to Portugal. In May, a further 1.5 metric tons (1,500kg) of the flower was shipped, according to customs documentation view by MJ Biz Daily.

Israel to reform cannabis laws

The Israeli government has passed a bill which could effectively decriminalise the possession of up to 50g of cannabis and the consumption up to 15g for over 21s. The Times of Israel reports that the leaders of the two biggest political parties and the police minister have backed the reform. In 2017, cannabis was partially decriminalised in the country and since then police are said to have eased enforcement of cannabis arrests for recreational use.

That’s a no then

The Food Standards Agency says there are no plans to extend the March 31, 2021 deadline for CBD companies to submit novel food applications. It was thought that an extension may be reasonable, given the country-wide effects of COVID-19 lockdown.

The good, the bad & the ugly

Hollywood heavyweight Clint Eastwood is suing three CBD companies, alleging they each created or distributed content falsely claiming he was endorsing their products, and that he had his own CBD line. Eastwood, 90, has no part in the manufacturing, or sale of CBD, according to the LA-filed law suit.

The medical cannabis economy

We often hear talk about the economic benefits of legalising cannabis, especially in the production sector. A recently published Grand View report estimated that the global legal cannabis market would be worth €73.6bn by 2027. Medical cannabis reportedly accounted for 71% of the legal cannabis market revenue in 2019.

GW Pharma envisages a strong end to 2020

Medical cannabis makers GW Pharma reportedly lost $8 million at the end of the first quarter but netted $311.3 million in sales at the end of last year. GW manufactures Epidyolex, which is one of two medical cannabis solutions approved for the NHS. CEO Justin Gover commented: “In this current environment caused by COVID-19, we have been able to support the epilepsy community remotely and maintain production of Epidyolex, while taking necessary steps to maintain the wellbeing of our employees. Looking ahead, GW is well placed to emerge strongly from the COVID-19 crisis with significant growth prospects for Epidyolex in the US and Europe, important pipeline clinical trials ready to execute, a strong balance sheet, and an unparalleled leading position in cannabinoid science.” The biopharmaceutical giant, which maintains a base in the UK, has additional cannabinoid product candidates in phase two trials for autism and schizophrenia.

Will Biden legalise cannabis?

The Democratic nominee for presidency in the US is said to be considering some of his former running mate Bernie Sanders’ progressive policy suggestions as he prepares to go head-to-head with Trump in the latter section of the year. An early draft of the Democratic Party platform which leaked in July hints at baby steps being made by the progressive arm of the party but falls short when it comes to endorsing legalisation of cannabis, according to Politico.

The New Oil Boom

In the years to come, the popularity of tinctures is set to mushroom rapidly, on account of these products being the most widely used for medical purposes. That’s according to a new report from Research and Markets which was published by Global Newswire in July. The market analytics store puts Aphria, Isodiol International, CV Sciences, Canopy Growth Corporation, Aurora Cannabis, Endoca, Tilray, CBDfx, Folium Biosciences, and Gaia Botanicals as the most dominant companies leading the way when it comes to oils.

Push & Pull

Attitudes towards hemp and CBD in the US are complex to say the least, with FDA regulation still a welcome possibility. In June, the state of Louisiana introduced penalties for the possession and sale of all smokable hemp products and all CBD-infused food and beverages (including alcohol). The move came as the state authorities say it cannot endorse such products for sale or consumption until there are FDA guidelines for manufacturers to adhere to. Meanwhile lobbyists from several health and consumer advocacy groups have written to US Congress in an appeal, “to reject any attempts to force federal regulators” to legalise CBD. Hemp Today reports that the campaigners agree Congress is, “not the right evaluator of the safety of consumer products” amid fears of representatives and senators being influenced by “well-funded profiteers.”

Delegates for Consumer Reports, The Public Health Institute, Consumer Federation of America, and the Center for Science in the Public Interest all reportedly signed the letter. Meanwhile in Nevada, thousands of cannabis convictions handed down prior to 2017 have been pardoned by the state’s governor.

STUCK IN THE MIDDLE WITH EU

Opinion by The Editor

Across the Atlantic in Washington DC where in mid-July the White House received two cannabis-related submissions from the US Food and Drug Administration (FDA).

One draft proposes guidance for clinical research on cannabis in the guise of a document called: Quality Considerations for Clinical Research Guidance for Industry. The other outlines proposed steps for enforcement for CBD products on sale in the US market space. FDA officials are understood to have submitted The Cannabidiol Enforcement Policy Draft Guidance for Industry to the White House Office of Management and Budget. This department must approve the proposal before it can go any further. It’s not yet known what the contents of this proposal set out, however it is hoped this move could mean clarity may finally be on the horizon for the US CBD space where things like labelling and a recommended daily intake are concerned. Within the same week, the European Commission announced it was considering the view that CBD may be more in line with narcotics than previously thought in a surprising move. A novel viewpoint to say the least, when one ponders the evidence and safety profile of the trending cannabinoid.

The Commission has paused novel food applications for now, the main talking point across the British and European industries for the past 18 months. To sum it up for anyone unfamiliar with this process, the Novel Food Regulations are a set of guidelines which depict what is and isn’t approved for the European food chain. The regulation of CBD as a novel food would see all consumable CBD products such as tinctures, gummies, capsules and more placed under food safety rules.

This new perspective, it’s thought, comes from a consideration of enforcing a labelling requirement which jumps from the CBD-is-a-food category to the ingredient being instead related to narcotics or psychotropics, in what could be a major step backwards for the CBD sector.

HERE’S WHERE IT GETS MORE COMPLICATED. THE MONEY.

So far, approximately 50 CBD companies have filed novel food applications and paid a sizeable fee to do so. Some have told me they have paid six figures per application, all in a bid to comply with the previous EU recommendation. The CANNAVIST has contacted the European Food Safety Authority to ask if such funds may be refunded in the future if CBD is in fact removed from the novel foods database. No response was received by the time of publication. EU food regulations, like many of the other EU pathways, can vary in levels of enforcement and interpretation among member states, which can lead to a patchwork pattern

forming across the continent. Naturally, the European Industrial Hemp Association (EIHA) has a lot to say on this matter. When the news was announced, the board of farmers, producers and processors released a statement titled: ‘The European Commission about to kill the hemp sector’.

The EIHA went on to say:

“The executive body of the European Union froze all applications of hemp extracts and natural cannabinoids under Novel Food regulation, considering them to be drugs. If confirmed, this position is likely to strike the final blow to the sector and deprive farmers from a low maintenance and profitable rotation crop with the potential to bringing environmental benefits. Cannabidiol would stay on the market but only in its synthetic form.”

WHAT WILL HAPPEN ON THE BLOC?

If CBD is labelled as a narcotic rather than a novel food, the European sector will be at risk. Large companies, particularly drug manufacturers, will be the sole beneficiaries where any natural extract is concerned. Small companies, start-ups and self-run operations, the cornerstone of the industry, will be under threat and many will be forced to close. Synthetic CBD will survive, but is that really what people want? A synthetic version of a readily available natural plant extract? The marketing alone would surely suffer.

The EU stance on narcotics, or controlled substances, adheres to the UN Convention system on narcotics and psychotropics. Both lists typically schedule drugs on three keys: a basis of risk, likelihood for abuse and likelihood of addiction. Therein lies the crucial word, ‘drugs’.

In a time where cannabis itself is becoming more tolerable, less stigmatised and having carved out a decriminalised corner of the health and wellness sector, its so far uncontrolled extract faces yet another roadblock on the journey to success.

WHERE DOES THIS LEAVE CBD IN THE UK?

Casting all politics aside, Brexit may be the saviour to the already burgeoning British CBD sector. As we come to the end of the transition period and the UK gears up to formally leave the EU, the Food Standards Agency will welcome compliant products to the market from April 1 next year.

The FSA has said CBD will not be classified as a narcotic in the UK meaning the industry here shouldn’t feel a negative impact from whatever the EU decides. The FSA will process novel food applications from January. In a response to a press request from The CANNAVIST a spokesperson for the authority said:

“The FSA will be formally accepting novel food applications from January 2021, after the Transition Period ends. The EC remains the route for formal submissions until that time. Narcotics are overseen by national legislation and the FSA’s view is consistent with the Home Office in that CBD extracts themselves are not considered narcotics. If a product is classified as a narcotic it would not be subject to novel food regulations.”

Novel food authorisation applications need to demonstrate that the CBD product in question is not subject to control under the Misuse of Drugs Act 1971, according to the FSA. If a CBD product is found to contain THC (or another controlled cannabinoid) it is highly likely that the product would be controlled at which point the Home Office may become involved. Further guidance is available from the Home Office factsheet “Cannabis, CBD and other cannabinoids”.

A BREAKDOWN OF THE HELP AVAILABLE TO CBD FIRMS IN THE UK HIT BY COVID-19

By CBD-Intel Editors

Companies in the UK which are struggling and in need of assistance due to lockdown rules in the face of the COVID-19 pandemic have several options to choose from, depending on their size and their needs. These include deferring VAT payments until March 31 2021, and claiming back sick pay.

The biggest scheme introduced by the UK is the Coronavirus Job Retention Scheme.

All employers are eligible for this scheme, which gives furloughed employees 80% of their salary, up to £2,500 a month. It only covers employees who are paid through the UK’s pay-as-you-earn (PAYE) tax system and employees must have been on the payroll on February 28. The programme was recently extended to last until the end of October.

Small and medium-sized companies which have been affected by the pandemic can apply for a Coronavirus Business Interruption loan.

Companies with a turnover of less than £45m who can demonstrate that they have been adversely affected by COVID-19 can receive loans and other financing, up to £5m. The government will guarantee 80% of the loan to the lender and will pay any interest and fees for the first 12 months.

A similar loan scheme is in place for companies with a turnover of more than £45m. At present these businesses may receive up to £25m (for turnover of £45m-£250m) or £50m (for turnover above £250m) in loans and financing.

As of May, the scheme has allowed companies to borrow up to 25% of turnover, up to a maximum of £200m, with banks underwriting 20% of the loan and the government

providing the remaining 80%. Dividend payouts will be prohibited as a condition of borrowing, though certain bonuses will still be permitted.

Smaller companies can also apply for a Bounce Back Loan

This is available between £2,000 and up to 25% of turnover, up to a maximum loan of £50,000, provided businesses can prove they have lost income due to COVID-19. The government guarantees 100% of the loan and there are no fees or interest for the first 12 months. After the first year, the interest rate will be 2.5%.

The Future Fund

The most recent scheme introduced by the British Government is the Future Fund. This allows start-ups which had raised at least £250,000 before the COVID-19 shutdown to receive up to £5m in funding from the government, provided a third party is willing to invest in the company. The scheme is aimed at companies that have not been able to benefit from other government relief measures and are in early stage development.

At present there are no EU-wide schemes to help businesses at a local level, although many EU countries have introduced their own economic relief packages, such as loan guarantees for businesses, deferment of taxes, state-backed aid, and other measures.

CBD-Intel (CBD-Intel.com) provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the worldwide cannabidiol (CBD) sector. We provide our clients with the tools to navigate this fast-moving sector, tailor their business strategy, optimise resources and make informed decisions. In addition, we offer customised research and consultancy support.

With cryptocurrencies poised to eliminate the costly middleman from virtually all industries and sectors, why should the lucrative CBD oil sector remain aloof?

R&R Naturals is among the top rated suppliers of high quality, full spectrum CBD (as well as contactless CBD), and is pleased to introduce Budcoin. The Budcoin

(thebudcointoken.com) is compared to a cryptocurrency but is an asset-based cashless system for the global CBD oil industry. The Budcoin is available for download at Thebudcointoken.com and can be exchanged for products anywhere that the Budcoin is accepted.

WALLET RETAILER

BUDCOIN

THE BIG FIVE

Medical or recreational, cannabis is big business. While more and more brands enter the market, five big hitters continue to dominate.

Words by Gordon Stribling, Assistant Editor

The global legal cannabis market is projected to reach $73.6 billion (USD) by 2027, according to a recent report by Grand View Research. CBD, medical cannabis, recreational cannabis and pharmaceuticals have made cannabis investment a hot prospect. Here is a rundown of the five big names currently leading the pack.

GW PHARMACEUTICALS

Founded: 1998

CEO: Justin Gover

2019 revenue: $311 million (USD)

Headquarters: Cambridge, UK

Subsidiaries: Greenwich Biosciences, Inc, GW Research Ltd. The UK is one of the biggest producers of medical cannabis in the world, exporting 95 tonnes in 2016 alone.

This British pharmaceutical giant has developed the only two cannabis-based medicines that are available on the NHS: Sativex, for multiple sclerosis patients and Epidyolex (Epidiolex in the US) for two rare types of epilepsy.

CANOPY GROWTH

Founded: 2013 (as Tweed Marijuana, Inc.)

CEO: David Klein

2019 revenue: $253 million (CA)

Headquarters: Smiths Falls, Canada

Subsidiaries: Spectrum Therapeutics. Canopy produces both medical and recreational cannabis. It operates 10 licensed production sites and has operations in

North America, South America, Europe, Asia and Australia. In 2019, Canopy set up a partnership with drug policy reform NGO Beckley Foundation to distribute medical cannabis in the UK. US drinks firm Constellation Brands owns a 38.5% stake in the company. It reportedly intends to launch a range of cannabis-infused beverages.

AURORA CANNABIS

Founded: 2006

CEO: Michael Singer

2019 revenue: $247.9 million (CA)

Headquarters: Edmonton, Canada

Subsidiaries include: MedReleaf Corp, Reliva, LLC

Aurora produces cannabis for the recreational and medical markets. The company has eight licensed

production facilities and operations in 25 countries, including Denmark, Uruguay, Australia and the UK.

Aurora’s research and development interests include CBD therapies for athletes through a partnership with the Ultimate Fighting Championship (UFC).

TILRAY

Founded: 2013

CEO: Brendan Kennedy

2019 revenue: $217.4million (CA)

Headquarters: Nanaimo, Canada

Subsidiaries: Fresh Hemp Foods Ltd, High Park Holdings Ltd

Tilray is a cannabis and pharmaceutical company with international operations in Europe, Latin America, Australia and New Zealand.

The company was the first cannabis producer to launch on the NASDAQ, the first North American medical cannabis producer to gain GMP certification and the first Canadian company to legally export cannabis to the US for a medical trial.

CRESCO LABS

Founded: 2013

2019 Revenue: $128.5million (USD)

Headquarters: Chicago, US

Subsidiaries: Cresco Labs, LLC, Hope Heal Health

Cresco Labs is a medical cannabis company with retail operations in seven of the medical-legal US states. It is one of the largest vertically integrated cannabis companies, controlling all stages of production, from cultivation to packaging.

The company has nine operational states, 15 production facilities, 29 retail licenses and owns 18 dispensaries.

CAN HEMP HELP GET THE ECONOMY GOING POST-LOCKDOWN?

Words by Caroline Barry

The British Government has floated the possibility of adopting a ‘green recovery’ plan to help get the economy moving post-lockdown. This, it’s thought, could also help the country achieve its zero-carbon emissions target. How can hemp help?

Lockdown has had a positive effect on the environment as its the longest period since the industrial revolution during which no coal has been burned.

In July, Chancellor Rishi Sunak announced details of the second phase of recovery focused on jobs. A further rebuilding phase is due to be rolled out later in the year. While the government hasn’t released details of what a green recovery plan might look like, hemp could almost certainly play a role.

So, setting CBD aside, how else can hemp be put to work in other sectors?

PLASTIC

Plastic pollution is currently one of the biggest environmental problems as our oceans are starting to fill up with micro particles, which are absorbed by fish, birds and animals, subsequently entering the food chain. Hemp can be used to make a variety of biodegradable items.

Once fibres have been removed from hemp stems, what remains is 77% cellulose, which is a light source that could replace petrochemical plastics. According to a Zion Market Research report, the global hemp packaging industry could reach $20 billion by 2025.

BIOACCUMULATION

One of hemp’s most beneficial attributes is its ability to absorb carbon dioxide, which is one of the key causes of climate change.

Hemp can absorb up to 15 tonnes of CO2 per hectare which makes it an extremely fast converter. It absorbs more of the compound per hectare than any other crop or commercial forestry.

The plant consumes four times more CO2 than trees and it has a short growth cycle of just 12 to 14 weeks.

HEMPCRETE

Hempcrete is a mixture of natural materials, lime and hemp and it could replace concrete. Hempcrete requires very little water in comparison to traditional concrete. It is also much more lightweight, with excellent thermal properties.

Hempcrete can be used to build, restore or renovate any type of building, making it an extremely versatile material. The industrial hemp industry is set to increase in worth from $4.6 billion to $26.6 billion by 2025 as legalisation continues, according to Markets and Markets researchers.

BIOMASS FUELS

Biomass fuel is an alternative to coal, oil and gas. The hemp plant is rich in cellulose and fibre that can be used in the production of fuel and energy.

The auto fuel derived from the biomass can be converted into methanol or ethanol and hemp seed oil can be used in the manufacturing of petrol.

HEMP FOODS

There are many nutritional benefits to be found in hemp. It’s an excellent form of plant-based protein and is suitable for vegans, plus it contains a large amount of essential amino acids that we do not produce in our own bodies. Hemp seeds can be added to yogurts, soups or salads but there are also hemp milks, oils and cooking pastes on the shelves of many supermarket chains, some of which also contain CBD for an extra health benefit.

Embracing hemp biomass fuel would reduce our dependency on fossil fuels while also releasing less CO 2 into the atmosphere. It is a greener and cleaner alternative. The

global hemp packaging industry could reach

CBD FOR PET’S SAKE.

IS THE UK MISSING A TRICK?

In the US, the CBD for pets sector is predicted to rise to a value of $563 million by the end of this year, while in the UK sales are prohibited.

Words by Caroline Barry

Let’s paws for a moment. If you are reading this in the UK, then you need to know that it is currently illegal to provide CBD to pets, unless you have a valid veterinary prescription which are hard to come by.

The British industry is missing out as the US market is estimated to bring in $563 million this year, according to data from the Brightfield Group.

The most recent figures published by the Office for National Statistics revealed that expenditure on pets and related products reached an annual value of £6.9 million in 2019.

Market researchers at Euromonitor International estimate that on average, the British population spends £74 per person on pets, with most of this spend going on food, making this an area where CBD could be applied easily for potential treatment of conditions ranging from anxiety to kidney failure.

It’s tempting to want to help our four-legged friends by giving them something alternative such as a few drops of CBD. But much like food items, some might not be suitable for their digestive systems or may interfere with medication.

WHAT DOES THE SCIENCE SAY?

There has been very little research on CBD for pets but there are some studies emerging from the US, albeit conducted in small numbers of animal participants and mainly on dogs. Veterinarians agree that THC is lethal for animals, especially smaller cats or dogs and that hemp-derived

CBD is far safer for them.

Like us humans, animals also have an endocannabinoid system. Some American pet owners have posted online about using it to help their animals with anxiety, cardiac issues, loss of appetite and stress. However, if your pet is on treatment for a condition, it could interact with their prescribed medication.

US LAW

In the United States, the federal government is working on regulations for the sale of CBD which includes the veterinary industry. However, this has yet to be implemented so the law does not currently ban CBD.

Some small studies show CBD can be beneficial to pets who suffer from conditions like epilepsy. A study by Colorado State University found that seizures in dogs were reduced by 89% when treated with THC-free oil. Idiopathic epilepsy affects 5.7% of the domesticated dog population worldwide, making it the most common canine neurological condition. In this Colorado study, nine dogs were treated with CBD, while seven in a control group were treated with a placebo. Dr. Stephanie McGrath, author of the study said in a statement:

“We saw a correlation between how high the levels of CBD oil were in these dogs with how great the seizure reduction was. It’s really exciting that perhaps we can start looking at CBD in the future as an alternative to existing anti-convulsive drugs.”

US vets are allowed to prescribe Epidiolex for canines but it is an expensive script at $30,000 a year for an average sized dog.

US INDUSTRY BOOM

Further research from the Brightfield Group reports a huge increase in the US CBD pet industry in 2019. The market grew over 10-fold compared to its 2018 size, producing $321 million in sales. It is projected to increase to $563 million by the end of 2020. The growth is reportedly being driven by pet owners looking for natural alternatives or options where traditional medication has failed. The most popular form of treatment is tinctures, followed by edibles such as treats or chews.

Where does this leave the future of CBD in pet products in the UK?

Sadly, pets on this side of the Atlantic may be missing out. Until more studies and live trials are completed showing positive benefits outweighing any risk of CBD-associated harm in animals, it seems unlikely the law will change anytime soon.

Spending on pets reached an annual value of £6.9 MILLION in the UK in 2019

Photos by @visualsbyb3ta @DestinyEarl

Passionate about plants, Kara Bragg also is adept at cultivating people.

Under Kara’s watchful eye and tender care, Sovereign Fields grew fourfold in less than a year. The hempseed and biomass company based in Southern Oregon develops world-class genetics for low-THC, highCBD boutique hemp strains. Kara also has consulted on recreational cannabis cultivation for Humboldt Seed Organization, represented at 12,000 retail outlets in 60 countries.

“We don’t want to be boastful,” said Kara, who serves as Sovereign Fields’ director of production. “We just want to be for everyone. We’re trying to inspire change.”

Anticipating changes in the United States’ legalities for farming hemp, Kara with Sovereign Fields co-founders Eric Foster and Ryan Davidson quickly constructed a business plan in 2018 and launched operations in 2019.

Kara, 39, already had been nurturing her own brand, Cannag1rl, an anonymous online growing journal showcasing Humboldt Seed Organization’s new genetics. Years of growing cannabis and perfecting plant lineage poised the three entities on the crest of North America’s “green wave.”

Kara had sown these seeds all her life. As a kid in Southern California, she learned to garden alongside her parents, who organized horticulture projects on family holidays. Awestruck at the transformation after transplanting a living organism to a new environment, Kara drew parallels between human and plant development, imagining that — like humans — plants experience emotions.

She learned in high school from a friend’s dad how to clone a plant — and what made it a “clone.” To find out what would take root and grow, Kara started cloning any plant that passed into her hands. Her friends soon dubbed her the “crazy plant lady,” a persona that defined the course of Kara’s life.

An advocate for medical cannabis, Kara never thought to grow her own until a friend gave her 12 seedlings with a feeding recipe and schedule. Initially unaware that she had embarked on an eight-month project, equipped with little except a green thumb for houseplants, Kara surprised herself with the plants’ success and was hooked.

After 10 years in the cannabis industry, managing and consulting for large-scale growing operations, Kara seeks every opportunity to learn more and, in turn, share insight with fellow growers and breeders, many of whom she considers mentors and friends.

The United Kingdom may have a long road ahead toward cannabis legalization, but Kara loves to spread the word that providing food — and medicine — for oneself is not only empowering, but not as hard as one would think.

Above all: “Don’t forget to drink water and get sun,” she said. “You’re basically a houseplant with complicated emotions!”

For growing tips and tricks, follow Kara’s Instagram journal @cannag1rl

Anyone who feels stuck or needs some growing advice should feel encouraged to contact Kara or ASK@CANNAVISTMAG.COM

THE NEXT BIG THING. GLOBAL BRANDS JOIN THE CBD INDUSTRY.

The CBD food, drink and beauty divisions are expected to increase dramatically in the next few years. We examine what products and growth we can expect from some of the world’s leading convenience brands.

Analysis by Caroline Barry

CBD is proving to be much more than just a trend as some of the most recognisable names in the world are investing to develop new products, testing facilities and acquiring start-ups.

The food and beverage industry is set to show the biggest growth with the US cannabis drinks arm on course to reach $1.4 billion by 2023, according to market research experts at Zenith Global. Meanwhile the beauty world, according to cannabis research powerhouse, P rohibition Partners, is set to hit $959 million by 2024.

OCEAN SPRAY

Industry: Cranberry juice, condiments and other drinks

Location: Massachusetts, US

CBD Interest : As part of their new product idea hub, the makers of the popular cranberry juice have released two new flavoured sparkling water drinks. The cans contain 10 and 20mg of CBD each, bolstered with vitamins A and E.

Growth: This is the multinational’s first move into the bottled or canned water sector which is set to rise to $334 billion by 2023.

NESTLÉ

Industry: Food & Beverages

Location: Switzerland

CBD Interest: Nestlé offers CBD oil and hemp capsules after brand experts for the household name identified CBD as a growing trend in healthcare, along with a growth in customer’s looking for more organic products. Nestlé also offers testing services for hemp and CBD quality and compliance.

Growth: By choosing to move into not just CBD product production, but also into research and the laboratory field, Nestlé has made one of the biggest commitments to the industry.

COLGATE & PALMOLIVE

Industry: Oral care (Colgate) and health products (Sanex and Palmolive)

Location: New York, US

CBD Interest: Colgate acquired Hello Products, a dental care company that offer a CBD and hemp range of products in the US in February of this year.

Growth: It will gain an online presence along with 44,000 US retail locations including one thousand Ulta Beauty storefronts. Available in the UK through Amazon.

ESTÉE LAUDER

Industry: Make up and skincare

Location: New York, US

CBD Interest: One of Estée Lauder’s skincare brands, Origins, released its first cannabis sativa products this year – the Hello Calm, Relaxing and Hydrating Face Mask.

Growth: The beautifying mask has been on sale since January but will be on sale in Sephora locations across the US from October. There are currently 460 standalone Sephora stores with a further 440 J.C.Penny locations across the US.

AVON

Product: Catalogue skincare and make-up

Location: London, UK

CBD Interest: A CBD-infused line of skincare products including two body creams and a facial oil with 100mg of CBD.

Growth: Hard to measure as Avon does not operate any physical stores, instead relying on a field representative selling system.

The food and beverage industry is set to show the biggest growth with the US cannabis drinks arm on course to reach $1.4 billion by 2023.

$1.4 billion

THE BOY WHO CHANGED THE LAW CHANGES THE SYSTEM

Billy Caldwell has been referred to new UK-wide forum

RESCAS ahead of landmark high court hearing.

Words by Róisín Delaney, The Editor

The boy who changed the law on medical cannabis, Billy Caldwell from Northern Ireland, has been referred to a new UK-wide forum for children with refractory epilepsy.

RESCAS, the Refractory Epilepsy Specialist Clinical Advisory Service, provides a forum for the discussion of difficult epilepsy cases that have presented diagnostic and/or management difficulties and have proven refractory to treatment.

The development comes as another landmark change for the British approach to medical cannabis, which the Caldwell family has been at the epicentre of for years. Billy, with the unwavering support of his mother Charlotte, set the pace for legalisation of medical cannabis from 2016, culminating in the then Home Secretary Sajid Javid giving the green light to legalisation on medical grounds in November 2018.

Announcing the news on the facebook page, Keep Billy Alive, proud mum Charlotte said:

“So excited to be able to tell you all following Billy’s reasonat consultation with Professor Helen Cross, GOSH [Great Ormond Street Hosptial], I have been notified – Billy’s case has been referred to RESCAS . This new service is a UK wide forum for children with refractory epilepsy to be assessed for Medical Cannabis and other treatment options. A UK first.”

Earlier in July, Billy’s legal case had been granted a high court hearing at Belfast Crown Court scheduled for September 7.

At the hearing, a judge could decide whether or not the NHS should cover the cost of Billy’s medical cannabis prescriptions, which he depends upon for any quality of life, according to mum Charlotte. This court hearing may still go ahead, should the outcome of any RESCAS decision be deemed unsuitable by the family’s legal representation.

Meanwhile, Charlotte has expressed her pride and delight of her young son’s achievements.

“I am SO SO proud of Billy.

“I would like to take this opportunity to thank Professor Helen Cross for her personal and professional support .

“This should now give new hope to many children like Billy.

“It is beyond valuable to me to know that as long as Billy gets his cannabis oil every day he will be safe. He won’t have a seizure.

“It’s actually a very amazing feeling. It feels like a safety blanket. When you have a child that has seizures

so bad that they can take his life from him – that feeling is absolutely incomparable to anything else. It’s priceless.

“Months and months at a time that he just gets to be a CHILD.

“It is everything.

“So many people have come together to form an awesome community surrounding this little boy and it’s absolutely amazing to see how cared for Billy is – and how much support, encouragement and love you have given us throughout the years.”

What is RESCAS?

The national Refractory Epilepsy Specialist Clinical Advisory Service (RESCAS) is made up of a network of UK based paediatric neurology specialists.

The service provides a forum for the discussion of difficult epilepsy cases that have presented diagnostic and/ or management difficulties and have proven refractory to treatment.

RESCAS is hosted at Great Ormond Street Hospital NHS Foundation Trust (GOSH) but is jointly run with paediatric neurologists from throughout the UK. The service has been commissioned by NHS England and is supported by NHS Scotland, NHS Wales, and Health and Social Care Northern Ireland.

“So many people have come together to form an awesome community surrounding this little boy and it’s absolutely amazing to see how cared for Billy is and how much support, encouragement and love you have given us throughout the years.”

PROJECT TWENTY21 ON TRACK

The largest European study of its kind aims to provide evidence of the efficacy of medical cannabis for a range of conditions.

Words by Gordon Stribling, Assistant Editor

The landmark Project Twenty21 medical cannabis register is still on track to launch to patients this summer.

The largest European project of its kind aims to provide a vast database of evidence gathered from medical cannabis patients with a range of conditions, from anxiety to chronic pain.

The team at Drug Science hopes that the data will inform wider prescribing of medical cannabis on the NHS.

The COVID-19 outbreak caused ‘major disruption’ to the development of the project. However, virtual appointments increased patient access and reduced the cost of private consultations.

In a recent update, the Project Twenty21 team said:

“The Project Twenty21 team completed the first test phase of the registry at the end of May 2020.

“Now the focus of the project is to increase the number of doctors who can prescribe medical cannabis, aiming for an official launch to patients in summer 2020.”

Project Twenty21 has partnered with five licensed cannabis producers who can provide various medical cannabis formulations at a significantly reduced cost of £150 per month.

There are currently just two types of medical cannabis available on the NHS.

Sativex, a 1:1 CBD:THC oral spray, can be prescribed for MS-related muscle spasticity where other treatments have been unsuccessful.

Epidyolex is used to treat LennoxGastaut syndrome and Dravet

syndrome: two rare types of epilepsy.

Meanwhile, Nabilone, a synthetic drug that mimics the effects of THC, is prescribed by specialist doctors to chemotherapy patients.

A Freedom of Information (FoA) request made public by The Guardian newspaper in June revealed that no new NHS patients had been prescribed full-extract cannabis oil since legalisation in 2018.

Drug Science Scientific Committee chair, Professor David Nutt, said:

“I suspect many doctors are afraid of cannabis after years of fear mongering and just want to be spoon-fed by the pharmaceutical industry.”

A WINDOW INTO THE WORLD OF CBD STUDIES

Although this year hasn’t gone according to plan for most, research on CBD & medical cannabis has continued despite COVID-19. We’ve handpicked four studies from this year you need to know about.

Words by Caroline Barry

DAYE CBD TAMPONS FOR ENDOMETRIOSIS PATIENTS

London-based tampon manufacturer, DAYE, has partnered with the North London NHS Trust to investigate CBD for endometriosis patients. Researchers are examining how CBD may help in pain relief for the chronic condition. The trial involving 80 women is now in its final stage and is due to culminate in August.

INFANT CANNABIS TRIAL GETS UNDERWAY

The world’s first cannabis medicine trial involving infants has started in the UK. A research team led by Guy’s and St Thomas NHS Foundation Trust in London, hopes the trial will help infants who are at risk of developing brain injuries or suffering from seizures. Two babies born in March have so far been enrolled in the trial. Oscar Parodi was the first baby to be offered the opportunity. Oscar was delivered by emergency cesarean at Norfolk and Norwich University Hospital (NNUH) on March 11. The babies are given a microdose of the cannabis-based drug within the first 12 hours of their lives. The amount administered is kept low at one thirtieth of the usual dose, according to the trial lead at Guys and St Thomas’. It will also involve other neonatal intensive care units in the UK and Europe taking up to a year to complete.

STUDY SHOWS CBG MAY HAVE POTENTIAL IN KILLING MRSA

Researchers at McMaster University in Canada recently published a paper showing that Cannabigerol (CBG) could kill a number of strains of MRSA, the antibiotic resistant staph bacterial infection. Tests showed the cannabinoid killed common MRSA microbes and ‘persister’ cells, which are resistant to antibiotics and can cause repeat infections. CBG also cleared up hard-to-kill ‘biofilms’ of MRSA that can form on the skin and in medical implants, according to researchers at McMaster.

Around 5 in every 100 people carry MRSA which can become deadly if vulnerable people are exposed to it.

CBD FOR COVID-19? RESEARCH SAYS IT MAY AID RECOVERY PROCESS

Researchers at Augusta University in Georgia have completed a study around CBD and COVID-19 recovery. The results suggest CBD could help with acute respiratory distress syndrome (ARDS), which is found in patients of severe COVID-19 symptoms, due to an overactive inflammatory response.

Researchers gave mice a treatment called Poly (I:C) which artificially induces ARDS, recreating symptoms seen in some COVID patients. This caused structural damages to the lungs of the mice similar to the damage seen in COVID patients and while they were experiencing these symptoms, the mice were given CBD.

The results showed that the mice experienced reduced signs of IL-6 which is an important factor in ARDS as well as lowered levels of pro-inflammatory cytokines. It also showed increases in lymphocyte levels in the blood which are vital in fighting infection. The researchers concluded CBD could play an immunotherapeutic role in treating some severe respiratory viral infections.

ASK THE SCIENTIST

In each issue of The CANNAVIST, our goto science columnists break down the complexities of CBD and medical cannabis so that we can all skip right to the needto-know knowledge and make informed decisions about what products to invest in.

Here, Dr Parveen Bhatarah, Regulatory & Compliance Lead at the Centre for Medicinal Cannabis, explains the significance of the Certificate of Analysis (COA).

Q. What is a COA?

A Certificate of Analysis is an authenticated document that is issued by a product manufacturer’s Quality Assurance Department. It ascertains if a product has met its predetermined product release specifications and quality.

The significance of the COA is growing under the globalisation and contract manufacturing culture – the white labelling industry.

Predetermined specifications are either based on standards set by national pharmacopoeia or an appropriate specification for each aspect of quality studied during the phase of development and during the validation of the

manufacturing process. At least those aspects considered to be critical should be the object of specifications routinely verified.

It establishes specifications, i.e. qualitative and quantitative characteristics, with test procedures and acceptance limits, with which the product must comply during its intended shelf life.

What should be included in the COA as a minimum?

1. Name & address of the laboratory testing the sample 2. Name & description of the originator requesting the analysis 3. Name & batch number of the product 4. Reference to the specifications used for testing

5. Results of all the tests performed against the limits of the specification

6. Dates: Expiry or re-test date & date on which tests were completed

7. Signatures of the head of the laboratory or other authorised person

The complexity of outsourcing supply chains means it’s crucial to understand all of the testing methodology as used per the COA generation. Especially when you are using this information to manufacture the finish a product and this can lead to incorrect labelling especially the

percentage declaration of contents. Therefore, a COA forms the basis of the mathematical correctness for finished product labelling.

verification exercise become part of key ingredient release before being used in production.

The mislabelling of CBD products has already been highlighted in various CBD product re-testing exercises as well as in consumer surveys. In June, the Centre for Medical Cannabis published the first major third-party testing exercise of CBD products in the UK. In total, 30 oil products available in the UK (both on and offline) were selected for the blind testing exercise. This revealed a wide range variation in terms of quality, and some concerning poor practice in a minority of cases.

When a supplier is new, the results of the COA are usually confirmed for each shipment of the material by performing independent verification of the test results. Therefore, it’s always a good practice to check incoming goods and verify or have a written contract where a

Once a history of reliable and accurate results from the supplier is established, the purchaser will often perform skip lot testing, in which they verify the COA results on a defined periodic basis, with the exception of the identity test, which should be performed for each incoming shipment.

1. IPEC: Certificate of Analysis Guide for Pharmaceutical Excipients, International Pharmaceutical Excipients Council.

2. World Health Organization: Guidelines on the Implementation of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce.

These certificates are a tangible and important manifestation of a manufacturer’s relationship with its suppliers of key raw material like CBD and the other materials used to make finished products. A COA supplied to the customer is the key document where the materials suppliers, laboratory control systems and manufacturing interconnect. Hence these certs are important documents for ensuring the safety of the supply chain and consumer confidence in a product.

3. DEFRA: Food standards (labelling and composition)

Buyer Beware!

If a retailer or manufacturer cannot provide you with a COA, completed by an independent lab, you can’t be sure of the quality of the ingredients, or if there is even any CBD in the product!

When labels go wrong...

Why do consumers need to know about COAs?

Three online resources for further guidance on COAs

FROM CALIFORNIA TO UK

California

cannabis in 2016. But it’s the CBD and wellness markets that present the greatest opportunity for expansion beyond state and international boundaries.

Words by Gordon Stribling, Assistant Editor

Over the past 18 months, the UK’s legal cannabis space has grown from a niche concern to spanning multiple industries.

It can now be considered a formidable sector of its own and continues to learn from and work with brands across the US.

One such experienced brand is Air Factory. The e-liquid firm’s journey began back in 2013. Over the past six months the company, now based in its own facility in Irvine, outside of Los Angeles, has dived head-first into the world of CBD and branched out internationally.

Air Factory’s Devin Ruzbasan recently moved to London so we thought we’d catch up and talk all things CBD.

“Our company is pretty diversified, so not only do we do Air Factory and CBD, we’re also in the process of opening up a cannabis testing lab,” Devin says.

“Most major cannabis companies are in Oregon, Washington or California, so we’re in the hub of the industry where it’s pretty easy to get accessories and the governance of the laws.”

“I mean, why wouldn’t you, right?”

Recreational cannabis has been legal in California since 2016 and the state

is now home to the world’s largest cannabis market, last year totalling close to $12 billion in estimated sales. But rather than capitalising on the thriving demand for legal THC-rich products, Air Factory has opted to go the broad-spectrum route, which opens doors not just beyond state lines but also to those who could be penalised for consumption, even in a legal state.

“Although cannabis is legal in California, if you go through a background check and you have THC in your body, you might not get the job.

“We wanted to have the effects of the CBD oils from the highest producing companies which is broad spectrum and we wanted to make sure that anybody who is using our products would not be penalised.”

While Air Factory established itself as a vape company, like many CBD brands operating today, it has since branched out into tinctures to appeal to, dare we say, a broader spectrum of customer.

legalised recreational

Devin Ruzbasan - Air Factory

Devin and Co. have also found that the CBD vape products didn’t really take off, with consumers sceptical about the benefits of vaping CBD and some no doubt unsettled by last year’s health scare across the US, despite the Center for Disease Control insisting that black market THC products were largely to blame.

Given the hostility towards vaping in the US these days and how readily CBD has been embraced by the wellness industry on both sides of the Atlantic, tapping into this new market was a no-brainer for this SoCal company.

“We’re going to stay on the wellness side of CBD, so the tinctures, perhaps the topicals, some other products.”

“We’ll start very slowly and navigate one piece at a time and evolve into more of a wellness product as opposed to a vaping product.”

Having begun to navigate the FDA’s rigorous tobacco product application process for their e-liquids, Air Factory is in a good position to start on the

long road to gaining novel foods authorisation on this side of the pond that will soon be the only route to market for tinctures and edibles in the UK.

“The FDA has just began opening their doors on what CBD will look like in the US and the UK has started a similar process. The intended goal is to do whatever it takes to get our products approved for sale in the UK going forward.”

“We wanted to make sure that anybody who is using our products would not be penalised”

86% OF AMERICANS ARE FAMILIAR WITH CBD

Words by Róisín Delaney

Anew study has shown that 1 in 5 Americans has used CBD, while 86% of the US adult population at least knows of the cannabinoid at this stage.

Among the US adult population, those aged between 35 and 54 are most likely to spend more than $100 on a CBD product.

Meanwhile 29% are likely to purchase CBD in the second half of 2020, with some linking this surge to an uptake in the cannabinoid’s profile to the health concerns brought on by COVID-19. The key findings come from a bilateral study led by two global data powerhouses in the largest US CBD consumer survey to date.

The US CBD Consumer Report, conducted in partnership by New Frontier Data and smart payment systems firm Square also shows that 60% of American CBD consumers report using CBD to unwind. This could be for relaxation, to relieve stress or anxiety.

New Frontier Data is an independent, technologydriven analytics company specialising in the global cannabis industry. Square founded the Square Reader, the smart tech payment system. The company now accepts CBD businesses and has offices in the UK and Ireland.

New Frontier Data CEO Giadha Aguirre de Carcer says consumer trends in the US cements America as the largest global CBD market of 2020.

“Our research shows that 1 in 5 Americans have used CBD, which demonstrates a major jump in consumer interest in the sector.

“While this phenomena is taking root across many other regions such as Europe and Latin America, the United States continues to represent the largest CBD market; understanding its CBD consumers is therefore a priority for enterprises

within both the legal cannabis industry and a multitude of mature sectors such as Food & Beverage or Health & Beauty.”

86%

J u s t some of t h e r e a so n s w h y YO U shoul d a d v e r t i se w i t h T he C A N N AV I S T

1 . W h en it c om e s to a d v e r t isi n g y o u r CB D b r a n d , t h e r e a r e n ’ t a s m a n y o p t ions a v ailabl a s y o u m i g h t t h in k .

Facebook, Instagram and Google do not permit sponsored posts or online ads for any cannabis derived product, including hemp based CBD. In order to reach the consume The CANNAVIST is your go to option on both sides of The Atlantic, with both trade and consumer distribution netwo in the US, UK and Ireland

2 . We' r e m a k i n g h i s to r y !

In January 2019, our magazine made history in becoming t first ever cannabis-based print publication available in the UK Fast forward to 2020 and you can now grab the la your local corner shop or WH Smith high st No other CBD publication in our markets can p same coverage for your brand.

3

. T h e Ma r k e t

8 4 million adults in Britain say they have already bought or intend to buy CBD in 20 Our magazine is the only accessible independen platform providing product reviews and th advice these consumers need

4 . Kn o w le d g e is k i n g

Through various media and education par with worldwide events and organisations li presents insights f rom the leading minds on CBD and medical cannabis

OUR CLIENTS A word from

“The CANNAVIST magazine is a great way of getting your brand name into the CBD market place here in the UK and across the pond in the USA. We advertise with The CANNAVIST on a regular basis and always get a good response via online sales or enquires. Carl and the team are on hand for advice and help with layout and design.”

- Craig Hamilton founder of Huna Labs, Nature’s Creations Limited

"The CANNAVIST is a great way to reach a new audience for us. We are very happy to work with a professional team. Carl is a great guy and is always available if I have any questions"

- Benjamin Foro, B-Chill

“We have a long-standing relationship with The CANNAVIST. We are proud to be partnered with The CANNAVIST and look forward to continuing to work with them."

- Collin Kerrigan, Marketing Director at Charlie’s Chalk Dust, creators of Pachamama CBD.

“It's been a pleasure working with The CANNAVIST. They are truly a team of professionals that provide timely support and on-point communication. The content of the magazine is also well curated and very relevant to industry trends. We look forward collaborating with The Cannavist again - Patty Sa, SpectrumLeaf Europe.

“It was an absolute pleasure working with Róisín and her team at The CANNAVIST at our latest event ‘Rising from the Ashes’ in King of Prussia, PA. The understanding that The CANNAVIST has regarding the many industry trends and issues is extraordinary. This enables The CANNAVIST to be our true media partner. We look forward to future events with The CANNAVIST.”

- Christina DiArcangelo, CEO, Affinity Bio Partners, Affinity Patient Advocacy, AI Health Outcomes and CannaBot.

“The CANNAVIST is an amazing new magazine to hit the US cannabis market offering access to great information about all things cannabis (and some things not). This media outlet has been an excellent way to get eyes on our products while the rest of the industry is heavily regulated and prohibits the advertisement of CBD products. Don’t take our word for it, grab your copy today and see exactly what we are talking about!”

“The CANNAVIST magazine team is fantastic to work with. They really understand our brands (Canna Club, Europe Canna Expo, London Canna Group), our clients’ brands and their objectives and always recommend and deliver partnerships that have performed above and beyond our expectations. The CANNAVIST has been instrumental for connecting us with the very niche readership and attracting people to our events. We are looking forward to another year of partnership.”

- Kristina Spionjak, Marketing Director, London Canna Group.

“I’ve had the pleasure of working with The CANNAVIST for the October issue and I must say that it was a delightful experience. The process of submitting the ad was easy to navigate. Pricing was clear and the steps to follow for submission detailed. My representative was even knowledgeable about advertising restrictions which I greatly appreciated. I am looking forward to working with The CANNAVIST again and I am ultra-excited about the US version!”

- Sabrenna Anderson-Smith, CEO, LillyPearlBeauty Co

We value the feedback we get from our clients. Here is what just some of our partners and friends of the magazine have said about working with us.